{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "c:\\Antoine\\Study\\Master 2 - MVA\\ALTEGRAD\\Altegrad-MVA-2023-2024\n"
     ]
    }
   ],
   "source": [
    "import sys, os\n",
    "\n",
    "path2add = os.path.normpath(os.path.abspath('..'))\n",
    "print(path2add)\n",
    "if not (path2add in sys.path) :\n",
    "    sys.path.append(path2add)\n",
    "\n",
    "\n",
    "import torch\n",
    "from dataloader import GraphDataset, GraphTextDataset, TextDataset, GraphTextInMDataset\n",
    "import networkx as nx\n",
    "\n",
    "from transformers import AutoTokenizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = AutoTokenizer.from_pretrained('nlpie/distil-biobert')#'microsoft/BiomedNLP-BiomedBERT-base-uncased-abstract-fulltext')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import shutil\n",
    "from tqdm import tqdm\n",
    "\n",
    "source_directory = r\"C:\\Antoine\\Study\\Master 2 - MVA\\ALTEGRAD\\Challenge\\Public\\Public\\data\"\n",
    "destination_directory = r\"C:\\Antoine\\Study\\Master 2 - MVA\\ALTEGRAD\\Altegrad-MVA-2023-2024\\data\"\n",
    "\n",
    "def move_files(source_directory, destination_directory):\n",
    "    # Make sure the destination directory exists, create it if not\n",
    "    if not os.path.exists(destination_directory):\n",
    "        os.makedirs(destination_directory)\n",
    "\n",
    "    # Get the total number of files to track progress\n",
    "    total_files = sum([len(files) for _, _, files in os.walk(source_directory)])\n",
    "\n",
    "    # Initialize the tqdm progress bar\n",
    "    progress_bar = tqdm(total=total_files, desc=\"Moving files\", unit=\"file\")\n",
    "\n",
    "    # Walk through the source directory and its subdirectories\n",
    "    for root, _, files in os.walk(source_directory):\n",
    "        for file_name in files:\n",
    "            source_path = os.path.join(root, file_name)\n",
    "            # Create the corresponding subdirectory structure in the destination\n",
    "            relative_path = os.path.relpath(source_path, source_directory)\n",
    "            destination_path = os.path.join(destination_directory, relative_path)\n",
    "\n",
    "            destination_dir = os.path.dirname(destination_path)\n",
    "            if not os.path.exists(destination_dir):\n",
    "                os.makedirs(destination_dir)\n",
    "\n",
    "\n",
    "            # Move the file\n",
    "            shutil.move(source_path, destination_path)\n",
    "\n",
    "            # Update the progress bar\n",
    "            progress_bar.update(1)\n",
    "\n",
    "    # Close the progress bar\n",
    "    progress_bar.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# move_files(source_directory, destination_directory)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "train_dir = r\"data/processed_nlpie/train/\"\n",
    "test_dir = r\"data/processed_nlpie/test/\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "sample = torch.load(train_dir + \"data.pt\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_datasets(tokenizer: AutoTokenizer):\n",
    "    gt = np.load(\"../data/token_embedding_dict.npy\", allow_pickle=True)[()]\n",
    "    val_dataset = GraphTextInMDataset(\n",
    "        root=\"../data/\", gt=gt, split=\"val\", tokenizer=tokenizer, model_name='nlpie/distil-biobert'\n",
    "    )\n",
    "    train_dataset = GraphTextInMDataset(\n",
    "        root=\"../data/\", gt=gt, split=\"train\", tokenizer=tokenizer, model_name='nlpie/distil-biobert'\n",
    "    )\n",
    "    return val_dataset, train_dataset\n",
    "\n",
    "val_dataset, train_dataset = load_datasets(tokenizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "sample = train_dataset[120]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "import textwrap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "def show_sample(sample):\n",
    "    edges = sample.edge_index\n",
    "    G = nx.DiGraph()\n",
    "\n",
    "    # Add edges to the graph\n",
    "    for i in range(len(edges[0])):\n",
    "        G.add_edge(int(edges[0][i]), int(edges[1][i]))\n",
    "\n",
    "    # Draw the graph\n",
    "    pos = nx.kamada_kawai_layout(G)\n",
    "    nx.draw(G, pos, with_labels=True, font_size=8, node_color='skyblue', node_size=200, edge_color='gray', linewidths=0.3, arrows=False)\n",
    "\n",
    "    # Show the plot\n",
    "    decoded_input = tokenizer.batch_decode(sample.input_ids, skip_special_tokens=True)[0]\n",
    "    wrapped_text = textwrap.fill(decoded_input, width=70)\n",
    "\n",
    "    print(sample.edge_index)\n",
    "\n",
    "    plt.text(0, -1, wrapped_text, ha='center', va='center', fontsize=8, bbox=dict(facecolor='white', alpha=0.4))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tensor([[ 0,  1,  1,  2,  1,  3,  3,  4,  4,  5,  5,  6,  6,  7,  6,  8,  5,  9,\n",
      "          9, 10, 10, 11, 11, 12, 11, 13, 10, 14, 14,  3],\n",
      "        [ 1,  0,  2,  1,  3,  1,  4,  3,  5,  4,  6,  5,  7,  6,  8,  6,  9,  5,\n",
      "         10,  9, 11, 10, 12, 11, 13, 11, 14, 10,  3, 14]])\n",
      "tensor([[ 0,  1,  1,  2,  1,  3,  3,  4,  4,  5,  5,  6,  6,  7,  7,  8,  8,  9,\n",
      "          9, 10, 10, 11, 11, 12, 11, 13],\n",
      "        [ 1,  0,  2,  1,  3,  1,  4,  3,  5,  4,  6,  5,  7,  6,  8,  7,  9,  8,\n",
      "         10,  9, 11, 10, 12, 11, 13, 11]])\n",
      "tensor([[ 0,  1,  1,  2,  1,  3,  3,  4,  4,  5,  5,  6,  6,  7,  7,  8,  8,  9,\n",
      "          9, 10,  9, 11, 11, 12, 12, 13, 13, 14, 14, 15, 15, 16, 16, 17, 17, 18,\n",
      "         18, 19, 19, 20, 20, 21, 21, 22, 22, 23, 23, 24, 23, 25],\n",
      "        [ 1,  0,  2,  1,  3,  1,  4,  3,  5,  4,  6,  5,  7,  6,  8,  7,  9,  8,\n",
      "         10,  9, 11,  9, 12, 11, 13, 12, 14, 13, 15, 14, 16, 15, 17, 16, 18, 17,\n",
      "         19, 18, 20, 19, 21, 20, 22, 21, 23, 22, 24, 23, 25, 23]])\n",
      "tensor([[ 0,  1,  1,  2,  1,  3,  3,  4,  4,  5,  5,  6,  6,  7,  7,  8,  8,  9,\n",
      "          7, 10, 10, 11, 11,  4],\n",
      "        [ 1,  0,  2,  1,  3,  1,  4,  3,  5,  4,  6,  5,  7,  6,  8,  7,  9,  8,\n",
      "         10,  7, 11, 10,  4, 11]])\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x1500 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(15, 15))\n",
    "\n",
    "plt.subplot(2, 2, 1)\n",
    "show_sample(train_dataset[452])\n",
    "plt.subplot(2, 2, 2)\n",
    "show_sample(train_dataset[785])\n",
    "plt.subplot(2, 2, 3)\n",
    "show_sample(train_dataset[4542])\n",
    "plt.subplot(2, 2, 4)\n",
    "show_sample(train_dataset[4277])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No sentence-transformers model found with name C:\\Users\\Antoine/.cache\\torch\\sentence_transformers\\microsoft_BiomedNLP-BiomedBERT-base-uncased-abstract-fulltext. Creating a new one with MEAN pooling.\n"
     ]
    }
   ],
   "source": [
    "from sentence_transformers import SentenceTransformer\n",
    "model = SentenceTransformer('microsoft/BiomedNLP-BiomedBERT-base-uncased-abstract-fulltext')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "decoded_input = tokenizer.batch_decode(train_dataset[41].input_ids, skip_special_tokens=True)[0]\n",
    "print(decoded_input)\n",
    "embedding = model.encode(\n",
    "    decoded_input\n",
    ")\n",
    "print(embedding.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "train_ds = pd.read_csv(\"./data/train.tsv\", sep=\"\\t\")\n",
    "val_ds = pd.read_csv(\"./data/val.tsv\", sep=\"\\t\")\n",
    "\n",
    "# Read data/test_text.txt into a list of strings\n",
    "with open(\"./data/test_text.txt\", \"r\") as f:\n",
    "    test_text = f.readlines()\n",
    "\n",
    "test_text = [text.strip() for text in test_text]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "ds = train_ds.iloc[:, 1].tolist() + val_ds.iloc[:, 1].tolist() + test_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'pd' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[1;32m~\\AppData\\Local\\Temp\\ipykernel_100860\\293564427.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[1;31m# Save to pandas dataframe\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 2\u001b[1;33m \u001b[0mdf\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mpd\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mDataFrame\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mds\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcolumns\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"text\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      3\u001b[0m \u001b[0mdf\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mto_csv\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"./data/text.csv\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mindex\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;32mFalse\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mNameError\u001b[0m: name 'pd' is not defined"
     ]
    }
   ],
   "source": [
    "# Save to pandas dataframe\n",
    "df = pd.DataFrame(ds, columns=[\"text\"])\n",
    "df.to_csv(\"./data/text.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Truncate the text to 512 tokens and add overflow to new rows\n",
    "df = pd.read_csv(\"./data/text.csv\")\n",
    "\n",
    "from transformers import AutoTokenizer\n",
    "tokenizer = AutoTokenizer.from_pretrained('microsoft/BiomedNLP-BiomedBERT-base-uncased-abstract-fulltext')\n",
    "\n",
    "def preprocess(samples):\n",
    "    batch_size = 64\n",
    "\n",
    "    tokenized = []\n",
    "    for i in range(0, len(samples), batch_size):\n",
    "        tokenized.append(tokenizer(samples[\"text\"][i:i+batch_size].tolist(), truncation=True, max_length=256, return_overflowing_tokens=True))\n",
    "    return tokenized\n",
    "\n",
    "tokenized = preprocess(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>input_ids</th>\n",
       "      <th>attention_mask</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...</td>\n",
       "      <td>[2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...</td>\n",
       "      <td>[2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...</td>\n",
       "      <td>[2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...</td>\n",
       "      <td>[2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...</td>\n",
       "      <td>[2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>[2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...</td>\n",
       "      <td>[2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>[2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...</td>\n",
       "      <td>[2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>[2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...</td>\n",
       "      <td>[2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>[2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...</td>\n",
       "      <td>[2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>[2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...</td>\n",
       "      <td>[2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>33331 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 text  \\\n",
       "0   [2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...   \n",
       "1   [2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...   \n",
       "2   [2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...   \n",
       "3   [2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...   \n",
       "4   [2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...   \n",
       "..                                                ...   \n",
       "43  [2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...   \n",
       "44  [2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...   \n",
       "45  [2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...   \n",
       "46  [2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...   \n",
       "47  [2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...   \n",
       "\n",
       "                                            input_ids  \\\n",
       "0   [2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...   \n",
       "1   [2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...   \n",
       "2   [2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...   \n",
       "3   [2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...   \n",
       "4   [2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...   \n",
       "..                                                ...   \n",
       "43  [2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...   \n",
       "44  [2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...   \n",
       "45  [2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...   \n",
       "46  [2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...   \n",
       "47  [2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...   \n",
       "\n",
       "                                       attention_mask  \n",
       "0   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "1   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "2   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "3   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "4   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "..                                                ...  \n",
       "43  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "44  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "45  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "46  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "47  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "\n",
       "[33331 rows x 3 columns]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.DataFrame(columns=[\"text\", \"input_ids\", \"attention_mask\"])\n",
    "for i in range(len(tokenized)):\n",
    "    # df = df.append(pd.DataFrame({\n",
    "    #     \"text\": tokenized[i][\"input_ids\"],\n",
    "    #     \"input_ids\": tokenized[i][\"input_ids\"],\n",
    "    #     \"attention_mask\": tokenized[i][\"attention_mask\"],\n",
    "    # }))\n",
    "    # Change append to concat\n",
    "    df = pd.concat([df, pd.DataFrame({\n",
    "        \"text\": tokenized[i][\"input_ids\"],\n",
    "        \"input_ids\": tokenized[i][\"input_ids\"],\n",
    "        \"attention_mask\": tokenized[i][\"attention_mask\"],\n",
    "    })])\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>input_ids</th>\n",
       "      <th>attention_mask</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...</td>\n",
       "      <td>[2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...</td>\n",
       "      <td>[2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...</td>\n",
       "      <td>[2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...</td>\n",
       "      <td>[2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...</td>\n",
       "      <td>[2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>[2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...</td>\n",
       "      <td>[2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>[2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...</td>\n",
       "      <td>[2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>[2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...</td>\n",
       "      <td>[2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>[2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...</td>\n",
       "      <td>[2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>[2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...</td>\n",
       "      <td>[2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...</td>\n",
       "      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>33331 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 text  \\\n",
       "0   [2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...   \n",
       "1   [2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...   \n",
       "2   [2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...   \n",
       "3   [2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...   \n",
       "4   [2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...   \n",
       "..                                                ...   \n",
       "43  [2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...   \n",
       "44  [2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...   \n",
       "45  [2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...   \n",
       "46  [2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...   \n",
       "47  [2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...   \n",
       "\n",
       "                                            input_ids  \\\n",
       "0   [2, 22, 17, 4118, 25238, 1037, 17, 22, 17, 163...   \n",
       "1   [2, 19406, 1935, 2687, 1977, 1925, 4595, 16, 1...   \n",
       "2   [2, 2136, 17, 2127, 17, 24, 17, 18588, 28038, ...   \n",
       "3   [2, 7843, 22, 17, 20990, 2928, 9286, 2010, 197...   \n",
       "4   [2, 10534, 5405, 2053, 12, 21, 15, 13, 1977, 1...   \n",
       "..                                                ...   \n",
       "43  [2, 12, 17659, 13, 17, 24321, 11800, 11123, 19...   \n",
       "44  [2, 12, 24, 17, 20990, 22467, 2199, 13, 29141,...   \n",
       "45  [2, 8298, 4151, 2057, 1977, 43, 3421, 5482, 19...   \n",
       "46  [2, 54, 17, 13489, 5482, 12, 21, 15, 13, 1977,...   \n",
       "47  [2, 26, 17, 21392, 2762, 14560, 17, 23, 11, 17...   \n",
       "\n",
       "                                       attention_mask  \n",
       "0   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "1   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "2   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "3   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "4   [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "..                                                ...  \n",
       "43  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "44  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "45  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "46  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "47  [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, ...  \n",
       "\n",
       "[33331 rows x 3 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.to_csv(\"./data/text_tokenized.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "train_ds = pd.read_csv(\"../data/train.tsv\", sep=\"\\t\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "texts = train_ds.iloc[:, 1].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "split_texts = []\n",
    "for i in range(len(texts)):\n",
    "    # Split for '. ' followed by a capital letter\n",
    "    split_texts.append(re.split(r'\\. (?=[A-Z])', texts[i]))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Counter({3: 9851,\n",
       "         4: 6448,\n",
       "         2: 6607,\n",
       "         5: 2288,\n",
       "         1: 707,\n",
       "         6: 423,\n",
       "         7: 72,\n",
       "         8: 8,\n",
       "         9: 3})"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lengths = [len(split_texts[i]) for i in range(len(split_texts))]\n",
    "# Counter for the lengths\n",
    "from collections import Counter\n",
    "Counter(lengths)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paromomycin is an amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. It has a role as an antibacterial drug, an antiprotozoal drug, an anthelminthic drug and an antiparasitic agent. It is an aminoglycoside antibiotic and an amino cyclitol glycoside. It derives from a streptamine. \n",
      "\n",
      "Paromomycin is an amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer)\n",
      "It is obtained from various Streptomyces species\n",
      "A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections\n",
      "It is also used as a therapeutic against visceral leishmaniasis\n",
      "It has a role as an antibacterial drug, an antiprotozoal drug, an anthelminthic drug and an antiparasitic agent\n",
      "It is an aminoglycoside antibiotic and an amino cyclitol glycoside\n",
      "It derives from a streptamine.\n",
      "\n",
      "3-bromopyruvic acid is a 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is replaced by bromine. Synthetic brominated derivative and structural analog of pyruvic acid. Highly reactive alkylating agent. Anti-cancer drug It has a role as an alkylating agent and an antineoplastic agent. It is a 2-oxo monocarboxylic acid and an organobromine compound. It derives from a pyruvic acid. It is a conjugate acid of a 3-bromopyruvate. \n",
      "\n",
      "3-bromopyruvic acid is a 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is replaced by bromine\n",
      "Synthetic brominated derivative and structural analog of pyruvic acid\n",
      "Highly reactive alkylating agent\n",
      "Anti-cancer drug It has a role as an alkylating agent and an antineoplastic agent\n",
      "It is a 2-oxo monocarboxylic acid and an organobromine compound\n",
      "It derives from a pyruvic acid\n",
      "It is a conjugate acid of a 3-bromopyruvate.\n",
      "\n",
      "D-serine is the R-enantiomer of serine. It has a role as a NMDA receptor agonist, a human metabolite and an Escherichia coli metabolite. It is a D-alpha-amino acid and a serine. It is a conjugate base of a D-serinium. It is a conjugate acid of a D-serinate. It is an enantiomer of a L-serine. It is a tautomer of a D-serine zwitterion. \n",
      "\n",
      "D-serine is the R-enantiomer of serine\n",
      "It has a role as a NMDA receptor agonist, a human metabolite and an Escherichia coli metabolite\n",
      "It is a D-alpha-amino acid and a serine\n",
      "It is a conjugate base of a D-serinium\n",
      "It is a conjugate acid of a D-serinate\n",
      "It is an enantiomer of a L-serine\n",
      "It is a tautomer of a D-serine zwitterion.\n",
      "\n",
      "L-histidine is the L-enantiomer of the amino acid histidine. It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is a proteinogenic amino acid, a histidine and a L-alpha-amino acid. It is a conjugate base of a L-histidinium(1+). It is a conjugate acid of a L-histidinate(1-). It is an enantiomer of a D-histidine. It is a tautomer of a L-histidine zwitterion. \n",
      "\n",
      "L-histidine is the L-enantiomer of the amino acid histidine\n",
      "It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite\n",
      "It is a proteinogenic amino acid, a histidine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-histidinium(1+)\n",
      "It is a conjugate acid of a L-histidinate(1-)\n",
      "It is an enantiomer of a D-histidine\n",
      "It is a tautomer of a L-histidine zwitterion.\n",
      "\n",
      "Nocamycin I is an organic heterotricyclic compound and tetramic acid derivative originally isolated from an unidentified oligosporic actinomycete strain (no. E864-861) and found to be active against both Gram-positive and Gram-negative anaerobic bacteria as well as some aerobic bacteria such as Streptococci. The methyl ester of nocamycin E. It has a role as an antibacterial agent and a bacterial metabolite. It is a spiroketal, a methyl ester, a gamma-lactam, an organic heterotricyclic compound, an olefinic compound, an enol and a member of tetramic acids. It derives from a nocamycin E. It is a conjugate acid of a nocamycin I(1-). \n",
      "\n",
      "Nocamycin I is an organic heterotricyclic compound and tetramic acid derivative originally isolated from an unidentified oligosporic actinomycete strain (no\n",
      "E864-861) and found to be active against both Gram-positive and Gram-negative anaerobic bacteria as well as some aerobic bacteria such as Streptococci\n",
      "The methyl ester of nocamycin E\n",
      "It has a role as an antibacterial agent and a bacterial metabolite\n",
      "It is a spiroketal, a methyl ester, a gamma-lactam, an organic heterotricyclic compound, an olefinic compound, an enol and a member of tetramic acids\n",
      "It derives from a nocamycin E\n",
      "It is a conjugate acid of a nocamycin I(1-).\n",
      "\n",
      "4-phenylbutyric acid is a monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation. It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an antineoplastic agent, an apoptosis inducer and a prodrug. It derives from a butyric acid. It is a conjugate acid of a 4-phenylbutyrate. \n",
      "\n",
      "4-phenylbutyric acid is a monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4\n",
      "It is a histone deacetylase inhibitor that displays anticancer activity\n",
      "It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells\n",
      "It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation\n",
      "It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an antineoplastic agent, an apoptosis inducer and a prodrug\n",
      "It derives from a butyric acid\n",
      "It is a conjugate acid of a 4-phenylbutyrate.\n",
      "\n",
      "L-mimosine is an L-alpha-amino acid that is propionic acid substituted by an amino group at position 2 and a 3-hydroxy-4-oxopyridin-1(4H)-yl group at position 3 (the 2S-stereoisomer). It a non-protein plant amino acid isolated from Mimosa pudica. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor and a plant metabolite. It is a non-proteinogenic L-alpha-amino acid and a member of 4-pyridones. It derives from a propionic acid. It is a conjugate acid of a L-mimosine(1-). It is a tautomer of a L-mimosine zwitterion. \n",
      "\n",
      "L-mimosine is an L-alpha-amino acid that is propionic acid substituted by an amino group at position 2 and a 3-hydroxy-4-oxopyridin-1(4H)-yl group at position 3 (the 2S-stereoisomer)\n",
      "It a non-protein plant amino acid isolated from Mimosa pudica\n",
      "It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor and a plant metabolite\n",
      "It is a non-proteinogenic L-alpha-amino acid and a member of 4-pyridones\n",
      "It derives from a propionic acid\n",
      "It is a conjugate acid of a L-mimosine(1-)\n",
      "It is a tautomer of a L-mimosine zwitterion.\n",
      "\n",
      "Benserazide is a carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone. It has a role as an EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor, an antiparkinson drug and a dopaminergic agent. It is a carbohydrazide, a member of catechols, a primary amino compound and a primary alcohol. It is a conjugate base of a benserazide(1+). \n",
      "\n",
      "Benserazide is a carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol\n",
      "An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism\n",
      "By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose\n",
      "Benserazide has no antiparkinson actions when given alone\n",
      "It has a role as an EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor, an antiparkinson drug and a dopaminergic agent\n",
      "It is a carbohydrazide, a member of catechols, a primary amino compound and a primary alcohol\n",
      "It is a conjugate base of a benserazide(1+).\n",
      "\n",
      "Monapinone E is a naphthopyran that is 3,4-dihydronaphtho[2,3-c]pyran-1-one which is substituted by a (2R,4R)-2,4,9-trihydroxynonyl group at position 3 and a methoxy group at position 7. Published in Acta Pharm. Sin. B, 2013, 3, 163-166. See also J. Antibiot., 2011, 64, 503-508. It is an aromatic ether, a member of phenols, a delta-lactone, a secondary alcohol, a primary alcohol and a naphtho-alpha-pyrone. \n",
      "\n",
      "Monapinone E is a naphthopyran that is 3,4-dihydronaphtho[2,3-c]pyran-1-one which is substituted by a (2R,4R)-2,4,9-trihydroxynonyl group at position 3 and a methoxy group at position 7\n",
      "Published in Acta Pharm\n",
      "Sin\n",
      "B, 2013, 3, 163-166\n",
      "See also J\n",
      "Antibiot., 2011, 64, 503-508\n",
      "It is an aromatic ether, a member of phenols, a delta-lactone, a secondary alcohol, a primary alcohol and a naphtho-alpha-pyrone.\n",
      "\n",
      "L-methionine is the L-enantiomer of methionine. It has a role as a nutraceutical, a micronutrient, an antidote to paracetamol poisoning, a human metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, a methionine and a L-alpha-amino acid. It is a conjugate base of a L-methioninium. It is a conjugate acid of a L-methioninate. It is an enantiomer of a D-methionine. It is a tautomer of a L-methionine zwitterion. \n",
      "\n",
      "L-methionine is the L-enantiomer of methionine\n",
      "It has a role as a nutraceutical, a micronutrient, an antidote to paracetamol poisoning, a human metabolite and a mouse metabolite\n",
      "It is an aspartate family amino acid, a proteinogenic amino acid, a methionine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-methioninium\n",
      "It is a conjugate acid of a L-methioninate\n",
      "It is an enantiomer of a D-methionine\n",
      "It is a tautomer of a L-methionine zwitterion.\n",
      "\n",
      "Irinotecan is a member of the class of pyranoindolizinoquinolines that is the carbamate ester obtained by formal condensation of the carboxy group of [1,4'-bipiperidine]-1'-carboxylic acid with the phenolic hydroxy group of (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2- hydrochloride]quinoline-3,14-dione. Used (in the form of its hydrochloride salt trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active. It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent and a prodrug. It is a pyranoindolizinoquinoline, a N-acylpiperidine, a carbamate ester, a tertiary alcohol, a tertiary amino compound, a delta-lactone and a ring assembly. It derives from a SN-38. It is a conjugate base of an irinotecan(1+). \n",
      "\n",
      "Irinotecan is a member of the class of pyranoindolizinoquinolines that is the carbamate ester obtained by formal condensation of the carboxy group of [1,4'-bipiperidine]-1'-carboxylic acid with the phenolic hydroxy group of (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2- hydrochloride]quinoline-3,14-dione\n",
      "Used (in the form of its hydrochloride salt trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy\n",
      "It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active\n",
      "It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent and a prodrug\n",
      "It is a pyranoindolizinoquinoline, a N-acylpiperidine, a carbamate ester, a tertiary alcohol, a tertiary amino compound, a delta-lactone and a ring assembly\n",
      "It derives from a SN-38\n",
      "It is a conjugate base of an irinotecan(1+).\n",
      "\n",
      "Methionine is a sulfur-containing amino acid that is butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4. It has a role as an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, a Daphnia magna metabolite and an algal metabolite. It is an alpha-amino acid and a sulfur-containing amino acid. It derives from a butyric acid. It is a conjugate base of a methioninium. It is a conjugate acid of a methioninate. It is a tautomer of a methionine zwitterion. \n",
      "\n",
      "Methionine is a sulfur-containing amino acid that is butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4\n",
      "It has a role as an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, a Daphnia magna metabolite and an algal metabolite\n",
      "It is an alpha-amino acid and a sulfur-containing amino acid\n",
      "It derives from a butyric acid\n",
      "It is a conjugate base of a methioninium\n",
      "It is a conjugate acid of a methioninate\n",
      "It is a tautomer of a methionine zwitterion.\n",
      "\n",
      "Lysine is a diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, a diamino acid and a polar amino acid. It contains a 4-aminobutyl group. It derives from a hexanoic acid. It is a conjugate base of a lysinium(1+). It is a conjugate acid of a lysinate. \n",
      "\n",
      "Lysine is a diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6\n",
      "It has a role as a Daphnia magna metabolite\n",
      "It is an alpha-amino acid, a diamino acid and a polar amino acid\n",
      "It contains a 4-aminobutyl group\n",
      "It derives from a hexanoic acid\n",
      "It is a conjugate base of a lysinium(1+)\n",
      "It is a conjugate acid of a lysinate.\n",
      "\n",
      "N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide is a hydrobromide salt prepared from N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol and one equivalent of hydrogen bromide. High affinity, selective dopamine D1-like receptor agonist. Ki values are 3.2, 3.1, 186, 66, 335, 1167, 1251 and 1385 nM at recombinant D1, D5, D2, D3, D4, 5-HT2A, alpha1A and alpha1B receptors respectively. Stimulates adenylyl cyclase (EC50 = 65 nM) but not phosphoinositide hydrolysis. Induces extreme arousal and hyperlocomotion following subcutaneous administration in monkeys. It has a role as a dopamine agonist and a prodrug. It contains a N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+). \n",
      "\n",
      "N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide is a hydrobromide salt prepared from N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol and one equivalent of hydrogen bromide\n",
      "High affinity, selective dopamine D1-like receptor agonist\n",
      "Ki values are 3.2, 3.1, 186, 66, 335, 1167, 1251 and 1385 nM at recombinant D1, D5, D2, D3, D4, 5-HT2A, alpha1A and alpha1B receptors respectively\n",
      "Stimulates adenylyl cyclase (EC50 = 65 nM) but not phosphoinositide hydrolysis\n",
      "Induces extreme arousal and hyperlocomotion following subcutaneous administration in monkeys\n",
      "It has a role as a dopamine agonist and a prodrug\n",
      "It contains a N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+).\n",
      "\n",
      "Ergothioneine is a L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group. A naturally occurring metabolite of histidine synthesized by bacteria and fungi with antioxidant properties. It is found ubiquitously in plants and animals and is present in many human foodstuffs. It has a role as an antioxidant, a fungal metabolite, a plant metabolite, a xenobiotic metabolite and a chelator. It is an amino-acid betaine, a L-histidine derivative and a sulfur-containing amino acid. It is a conjugate base of an ergothioneine(1+). It is a tautomer of an ergothioneine thione form. \n",
      "\n",
      "Ergothioneine is a L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group\n",
      "A naturally occurring metabolite of histidine synthesized by bacteria and fungi with antioxidant properties\n",
      "It is found ubiquitously in plants and animals and is present in many human foodstuffs\n",
      "It has a role as an antioxidant, a fungal metabolite, a plant metabolite, a xenobiotic metabolite and a chelator\n",
      "It is an amino-acid betaine, a L-histidine derivative and a sulfur-containing amino acid\n",
      "It is a conjugate base of an ergothioneine(1+)\n",
      "It is a tautomer of an ergothioneine thione form.\n",
      "\n",
      "TMC-52A is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-tyrosinamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52A acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 320 nM, 13 nM, and 44 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S). It has a role as an antimicrobial agent, a cathepsin L (EC 3.4.22.15) inhibitor, an EC 3.4.22.2 (papain) inhibitor, a cathepsin B inhibitor and a fungal metabolite. It is an epoxide, a monocarboxylic acid, a member of phenols, a primary amino compound, a secondary amino compound and a dicarboxylic acid monoamide. \n",
      "\n",
      "TMC-52A is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-tyrosinamide\n",
      "It is a natural product, isolated from Gliocladium sp\n",
      "F-2665\n",
      "TMC-52A acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 320 nM, 13 nM, and 44 nM, respectively\n",
      "The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S)\n",
      "It has a role as an antimicrobial agent, a cathepsin L (EC 3.4.22.15) inhibitor, an EC 3.4.22.2 (papain) inhibitor, a cathepsin B inhibitor and a fungal metabolite\n",
      "It is an epoxide, a monocarboxylic acid, a member of phenols, a primary amino compound, a secondary amino compound and a dicarboxylic acid monoamide.\n",
      "\n",
      "Oxycodone is a semisynthetic opioid of formula C18H21NO4 that is derived from thebaine. It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain. It has a role as an opioid analgesic, a mu-opioid receptor agonist and an antitussive. It is an organic heteropentacyclic compound and a semisynthetic derivative. It derives from a thebaine. It is a conjugate base of an oxycodone(1+). It derives from a hydride of a morphinan. \n",
      "\n",
      "Oxycodone is a semisynthetic opioid of formula C18H21NO4 that is derived from thebaine\n",
      "It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain\n",
      "It has a role as an opioid analgesic, a mu-opioid receptor agonist and an antitussive\n",
      "It is an organic heteropentacyclic compound and a semisynthetic derivative\n",
      "It derives from a thebaine\n",
      "It is a conjugate base of an oxycodone(1+)\n",
      "It derives from a hydride of a morphinan.\n",
      "\n",
      "D-glutamine is the D-enantiomer of glutamine. It has a role as a mouse metabolite. It is a D-alpha-amino acid and a glutamine. It is a conjugate base of a D-glutaminium. It is a conjugate acid of a D-glutaminate. It is an enantiomer of a L-glutamine. It is a tautomer of a D-glutamine zwitterion. \n",
      "\n",
      "D-glutamine is the D-enantiomer of glutamine\n",
      "It has a role as a mouse metabolite\n",
      "It is a D-alpha-amino acid and a glutamine\n",
      "It is a conjugate base of a D-glutaminium\n",
      "It is a conjugate acid of a D-glutaminate\n",
      "It is an enantiomer of a L-glutamine\n",
      "It is a tautomer of a D-glutamine zwitterion.\n",
      "\n",
      "TMC-52B is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{4-[(3-aminopropyl)amino]butyl}-L-tyrosinamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52B acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 200 nM, 10 nM, and 7 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S). It has a role as a metabolite, an antimicrobial agent, a cathepsin B inhibitor, a cathepsin L (EC 3.4.22.15) inhibitor and an EC 3.4.22.2 (papain) inhibitor. It is an epoxide, a monocarboxylic acid, a member of phenols, a primary amino compound and a secondary amino compound. \n",
      "\n",
      "TMC-52B is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{4-[(3-aminopropyl)amino]butyl}-L-tyrosinamide\n",
      "It is a natural product, isolated from Gliocladium sp\n",
      "F-2665\n",
      "TMC-52B acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 200 nM, 10 nM, and 7 nM, respectively\n",
      "The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S)\n",
      "It has a role as a metabolite, an antimicrobial agent, a cathepsin B inhibitor, a cathepsin L (EC 3.4.22.15) inhibitor and an EC 3.4.22.2 (papain) inhibitor\n",
      "It is an epoxide, a monocarboxylic acid, a member of phenols, a primary amino compound and a secondary amino compound.\n",
      "\n",
      "D-histidine is an optically active form of histidine having D-configuration. It has a role as a Saccharomyces cerevisiae metabolite. It is a D-alpha-amino acid and a histidine. It is a conjugate base of a D-histidinium(1+). It is a conjugate acid of a D-histidinate(1-). It is an enantiomer of a L-histidine. It is a tautomer of a D-histidine zwitterion. \n",
      "\n",
      "D-histidine is an optically active form of histidine having D-configuration\n",
      "It has a role as a Saccharomyces cerevisiae metabolite\n",
      "It is a D-alpha-amino acid and a histidine\n",
      "It is a conjugate base of a D-histidinium(1+)\n",
      "It is a conjugate acid of a D-histidinate(1-)\n",
      "It is an enantiomer of a L-histidine\n",
      "It is a tautomer of a D-histidine zwitterion.\n",
      "\n",
      "Bromfenac is amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure. It has a role as a non-steroidal anti-inflammatory drug and a non-narcotic analgesic. It is a member of benzophenones, a substituted aniline, an aromatic amino acid and an organobromine compound. It derives from an amfenac. It is a conjugate acid of a bromfenac(1-). \n",
      "\n",
      "Bromfenac is amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine\n",
      "It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction\n",
      "It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure\n",
      "It has a role as a non-steroidal anti-inflammatory drug and a non-narcotic analgesic\n",
      "It is a member of benzophenones, a substituted aniline, an aromatic amino acid and an organobromine compound\n",
      "It derives from an amfenac\n",
      "It is a conjugate acid of a bromfenac(1-).\n",
      "\n",
      "Dimenhydrinate is the diphenhydramine salt of 8-chlorotheophylline. Its effects are similar to those of diphenhydramine, but it is less potent. It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated. However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline. Dimenhydrinate is used mainly as an antiemetic in the prevention and treatment of motion sickness. It has a role as a H1-receptor antagonist and an antiemetic. It contains a diphenhydramine and an 8-chlorotheophylline(1-). \n",
      "\n",
      "Dimenhydrinate is the diphenhydramine salt of 8-chlorotheophylline\n",
      "Its effects are similar to those of diphenhydramine, but it is less potent\n",
      "It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated\n",
      "However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline\n",
      "Dimenhydrinate is used mainly as an antiemetic in the prevention and treatment of motion sickness\n",
      "It has a role as a H1-receptor antagonist and an antiemetic\n",
      "It contains a diphenhydramine and an 8-chlorotheophylline(1-).\n",
      "\n",
      "2-acetyl-1-pyrroline is a pyrroline that is 1-pyrroline in which the hydrogen at position 2 is replaced by an acetyl group. It is an aroma and flavour compound present in jasmine rice and basmati rice. It is responsible for the 'popcorn' aroma in a large variety of cereal and food products. It is one of the key odourants of the crust of bread and considered to be responsible for the cracker-like odour properties. In bread, it is primarily generated during baking but amounts are influenced by ingredient composition and fermentation conditions. It has a role as a metabolite, a flavouring agent and a Maillard reaction product. It is a methyl ketone, a pyrroline and an acylimine. \n",
      "\n",
      "2-acetyl-1-pyrroline is a pyrroline that is 1-pyrroline in which the hydrogen at position 2 is replaced by an acetyl group\n",
      "It is an aroma and flavour compound present in jasmine rice and basmati rice\n",
      "It is responsible for the 'popcorn' aroma in a large variety of cereal and food products\n",
      "It is one of the key odourants of the crust of bread and considered to be responsible for the cracker-like odour properties\n",
      "In bread, it is primarily generated during baking but amounts are influenced by ingredient composition and fermentation conditions\n",
      "It has a role as a metabolite, a flavouring agent and a Maillard reaction product\n",
      "It is a methyl ketone, a pyrroline and an acylimine.\n",
      "\n",
      "L-threonine is an optically active form of threonine having L-configuration. It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, a plant metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, a threonine and a L-alpha-amino acid. It is a conjugate base of a L-threoninium. It is a conjugate acid of a L-threoninate. It is an enantiomer of a D-threonine. It is a tautomer of a L-threonine zwitterion. \n",
      "\n",
      "L-threonine is an optically active form of threonine having L-configuration\n",
      "It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, a plant metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite\n",
      "It is an aspartate family amino acid, a proteinogenic amino acid, a threonine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-threoninium\n",
      "It is a conjugate acid of a L-threoninate\n",
      "It is an enantiomer of a D-threonine\n",
      "It is a tautomer of a L-threonine zwitterion.\n",
      "\n",
      "L-cysteine is an optically active form of cysteine having L-configuration. It has a role as a flour treatment agent, a human metabolite and an EC 4.3.1.3 (histidine ammonia-lyase) inhibitor. It is a serine family amino acid, a proteinogenic amino acid, a cysteine and a L-alpha-amino acid. It is a conjugate base of a L-cysteinium. It is a conjugate acid of a L-cysteinate(1-). It is an enantiomer of a D-cysteine. It is a tautomer of a L-cysteine zwitterion. \n",
      "\n",
      "L-cysteine is an optically active form of cysteine having L-configuration\n",
      "It has a role as a flour treatment agent, a human metabolite and an EC 4.3.1.3 (histidine ammonia-lyase) inhibitor\n",
      "It is a serine family amino acid, a proteinogenic amino acid, a cysteine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-cysteinium\n",
      "It is a conjugate acid of a L-cysteinate(1-)\n",
      "It is an enantiomer of a D-cysteine\n",
      "It is a tautomer of a L-cysteine zwitterion.\n",
      "\n",
      "Cilastatin is the thioether resulting from the formal oxidative coupling of the thiol group of L-cysteine with the 7-position of (2Z)-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid. It is an inhibitor of dehydropeptidase I (membrane dipeptidase, 3.4.13.19), an enzyme found in the brush border of renal tubes and responsible for degrading the antibiotic imipenem. Cilastatin is therefore administered (as the sodium salt) with imipenem to prolong the antibacterial effect of the latter by preventing its renal metabolism to inactive and potentially nephrotoxic products. Cilastatin also acts as a leukotriene D4 dipeptidase inhibitor, preventing the metabolism of leukotriene D4 to leukotriene E4. It has a role as a protease inhibitor, an EC 3.4.13.19 (membrane dipeptidase) inhibitor, a xenobiotic and an environmental contaminant. It is a non-proteinogenic L-alpha-amino acid, a L-cysteine derivative, an organic sulfide and a carboxamide. It is a conjugate acid of a cilastatin(1-). \n",
      "\n",
      "Cilastatin is the thioether resulting from the formal oxidative coupling of the thiol group of L-cysteine with the 7-position of (2Z)-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid\n",
      "It is an inhibitor of dehydropeptidase I (membrane dipeptidase, 3.4.13.19), an enzyme found in the brush border of renal tubes and responsible for degrading the antibiotic imipenem\n",
      "Cilastatin is therefore administered (as the sodium salt) with imipenem to prolong the antibacterial effect of the latter by preventing its renal metabolism to inactive and potentially nephrotoxic products\n",
      "Cilastatin also acts as a leukotriene D4 dipeptidase inhibitor, preventing the metabolism of leukotriene D4 to leukotriene E4\n",
      "It has a role as a protease inhibitor, an EC 3.4.13.19 (membrane dipeptidase) inhibitor, a xenobiotic and an environmental contaminant\n",
      "It is a non-proteinogenic L-alpha-amino acid, a L-cysteine derivative, an organic sulfide and a carboxamide\n",
      "It is a conjugate acid of a cilastatin(1-).\n",
      "\n",
      "3-hydroxy-3-methylglutaric acid is a dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura. It has a role as an antimetabolite, an anticholesteremic drug, an EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor, a human metabolite and a plant metabolite. It is a dicarboxylic acid, a 3-hydroxy carboxylic acid and a tertiary alcohol. It derives from a glutaric acid. It is a conjugate acid of a 3-hydroxy-3-methylglutarate(1-). \n",
      "\n",
      "3-hydroxy-3-methylglutaric acid is a dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group\n",
      "It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency\n",
      "It occurs as a plant metabolite in Crotalaria dura\n",
      "It has a role as an antimetabolite, an anticholesteremic drug, an EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor, a human metabolite and a plant metabolite\n",
      "It is a dicarboxylic acid, a 3-hydroxy carboxylic acid and a tertiary alcohol\n",
      "It derives from a glutaric acid\n",
      "It is a conjugate acid of a 3-hydroxy-3-methylglutarate(1-).\n",
      "\n",
      "Fosinopril is a phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, a prodrug and an antihypertensive agent. It is a phosphinic ester and a L-proline derivative. It derives from a fosinoprilat. It is a conjugate acid of a fosinopril(1-). \n",
      "\n",
      "Fosinopril is a phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline\n",
      "It is used for the treatment of hypertension and heart failure\n",
      "A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite\n",
      "It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, a prodrug and an antihypertensive agent\n",
      "It is a phosphinic ester and a L-proline derivative\n",
      "It derives from a fosinoprilat\n",
      "It is a conjugate acid of a fosinopril(1-).\n",
      "\n",
      "Aspirin-based probe AP is a benzoate ester resulting from the formal condensation of the carboxy group of acetylsalicylic acid with the phenolic hydroxy group of 2-(1,3-benzothiazol-2-yl)-4-fluorophenol. The latter is a fluorophore which is to the aspirin moiety via an H2O2-responsive bond. It can be used as probe for imaging H2O2 (overproduction of H2O2 causes oxidative stress and is characteristic of vascular diseases). In contrast to arylboronat-based probes, it shows high specificity for H2O2 over peroxynitrite (which is much more reactive than H2O2, but exists at much lower abundance). It has a role as a pharmaceutical. It is a benzoate ester, a member of benzothiazoles, a member of monofluorobenzenes and a member of salicylates. It derives from an acetylsalicylic acid and a 2-(1,3-benzothiazol-2-yl)-4-fluorophenol. \n",
      "\n",
      "Aspirin-based probe AP is a benzoate ester resulting from the formal condensation of the carboxy group of acetylsalicylic acid with the phenolic hydroxy group of 2-(1,3-benzothiazol-2-yl)-4-fluorophenol\n",
      "The latter is a fluorophore which is to the aspirin moiety via an H2O2-responsive bond\n",
      "It can be used as probe for imaging H2O2 (overproduction of H2O2 causes oxidative stress and is characteristic of vascular diseases)\n",
      "In contrast to arylboronat-based probes, it shows high specificity for H2O2 over peroxynitrite (which is much more reactive than H2O2, but exists at much lower abundance)\n",
      "It has a role as a pharmaceutical\n",
      "It is a benzoate ester, a member of benzothiazoles, a member of monofluorobenzenes and a member of salicylates\n",
      "It derives from an acetylsalicylic acid and a 2-(1,3-benzothiazol-2-yl)-4-fluorophenol.\n",
      "\n",
      "L-serine is the L-enantiomer of serine. It has a role as a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a serine family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and a serine. It is a conjugate base of a L-serinium. It is a conjugate acid of a L-serinate. It is an enantiomer of a D-serine. It is a tautomer of a L-serine zwitterion. \n",
      "\n",
      "L-serine is the L-enantiomer of serine\n",
      "It has a role as a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite\n",
      "It is a serine family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and a serine\n",
      "It is a conjugate base of a L-serinium\n",
      "It is a conjugate acid of a L-serinate\n",
      "It is an enantiomer of a D-serine\n",
      "It is a tautomer of a L-serine zwitterion.\n",
      "\n",
      "Flufenpyr-ethyl is an ethyl ester resulting from the formal condesnation of the carboxy group of flufenpyr with ethanol. It is used as a contact herbicide for the control of broad-leaved weeds. It acts as a protoporphyrinogen oxidase inhibitor, causing protoporphyrins to accumulate, damaging the membrane structure and cellular function. No longer approved for use in the European Union. It has a role as a herbicide, an agrochemical and an EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor. It is an ethyl ester, an aromatic ether, a pyridazinone, a member of monofluorobenzenes and a member of monochlorobenzenes. It derives from a flufenpyr. \n",
      "\n",
      "Flufenpyr-ethyl is an ethyl ester resulting from the formal condesnation of the carboxy group of flufenpyr with ethanol\n",
      "It is used as a contact herbicide for the control of broad-leaved weeds\n",
      "It acts as a protoporphyrinogen oxidase inhibitor, causing protoporphyrins to accumulate, damaging the membrane structure and cellular function\n",
      "No longer approved for use in the European Union\n",
      "It has a role as a herbicide, an agrochemical and an EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor\n",
      "It is an ethyl ester, an aromatic ether, a pyridazinone, a member of monofluorobenzenes and a member of monochlorobenzenes\n",
      "It derives from a flufenpyr.\n",
      "\n",
      "Vanoxerine dihydrochloride is a hydrochloride salt that is obtained by reaction of vanoxerine with two equivalents of hydrogen chloride. Potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers. Also a potent sigma ligand (IC50 = 48 nM). Centrally active following systemic administration. It has a role as a dopamine uptake inhibitor. It contains a vanoxerine(2+). \n",
      "\n",
      "Vanoxerine dihydrochloride is a hydrochloride salt that is obtained by reaction of vanoxerine with two equivalents of hydrogen chloride\n",
      "Potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake)\n",
      "Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers\n",
      "Also a potent sigma ligand (IC50 = 48 nM)\n",
      "Centrally active following systemic administration\n",
      "It has a role as a dopamine uptake inhibitor\n",
      "It contains a vanoxerine(2+).\n",
      "\n",
      "L-lysine is an L-alpha-amino acid; the L-isomer of lysine. It has a role as a micronutrient, a nutraceutical, an anticonvulsant, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, a lysine and a L-alpha-amino acid. It is a conjugate base of a L-lysinium(1+). It is a conjugate acid of a L-lysinate. It is an enantiomer of a D-lysine. It is a tautomer of a L-lysine zwitterion. \n",
      "\n",
      "L-lysine is an L-alpha-amino acid; the L-isomer of lysine\n",
      "It has a role as a micronutrient, a nutraceutical, an anticonvulsant, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite\n",
      "It is an aspartate family amino acid, a proteinogenic amino acid, a lysine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-lysinium(1+)\n",
      "It is a conjugate acid of a L-lysinate\n",
      "It is an enantiomer of a D-lysine\n",
      "It is a tautomer of a L-lysine zwitterion.\n",
      "\n",
      "Stanozolol is an organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders. It has also been widely abused by professional athletes. It has a role as an androgen and an anabolic agent. It is a 17beta-hydroxy steroid, a tertiary alcohol, an anabolic androgenic steroid and an organic heteropentacyclic compound. It derives from an oxymetholone. \n",
      "\n",
      "Stanozolol is an organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine\n",
      "Like oxymetholone, it is a synthetic anabolic steroid\n",
      "It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders\n",
      "It has also been widely abused by professional athletes\n",
      "It has a role as an androgen and an anabolic agent\n",
      "It is a 17beta-hydroxy steroid, a tertiary alcohol, an anabolic androgenic steroid and an organic heteropentacyclic compound\n",
      "It derives from an oxymetholone.\n",
      "\n",
      "Fludarabine phosphate is a purine arabinonucleoside monophosphate having 2-fluoroadenine as the nucleobase. A prodrug, it is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. Once incorporated into DNA, 2-fluoro-ara-ATP functions as a DNA chain terminator. It is used for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to, or whose disease has progressed during, treatment with at least one standard alkylating-agent containing regimenas. It has a role as an antimetabolite, an antineoplastic agent, an immunosuppressive agent, an antiviral agent, a prodrug and a DNA synthesis inhibitor. It is an organofluorine compound, a nucleoside analogue and a purine arabinonucleoside monophosphate. It derives from a 2-fluoroadenine. \n",
      "\n",
      "Fludarabine phosphate is a purine arabinonucleoside monophosphate having 2-fluoroadenine as the nucleobase\n",
      "A prodrug, it is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP\n",
      "Once incorporated into DNA, 2-fluoro-ara-ATP functions as a DNA chain terminator\n",
      "It is used for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to, or whose disease has progressed during, treatment with at least one standard alkylating-agent containing regimenas\n",
      "It has a role as an antimetabolite, an antineoplastic agent, an immunosuppressive agent, an antiviral agent, a prodrug and a DNA synthesis inhibitor\n",
      "It is an organofluorine compound, a nucleoside analogue and a purine arabinonucleoside monophosphate\n",
      "It derives from a 2-fluoroadenine.\n",
      "\n",
      "L-isoleucine is the L-enantiomer of isoleucine. It has a role as a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, an isoleucine and a L-alpha-amino acid. It is a conjugate base of a L-isoleucinium. It is a conjugate acid of a L-isoleucinate. It is an enantiomer of a D-isoleucine. It is a tautomer of a L-isoleucine zwitterion. \n",
      "\n",
      "L-isoleucine is the L-enantiomer of isoleucine\n",
      "It has a role as a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite\n",
      "It is an aspartate family amino acid, a proteinogenic amino acid, an isoleucine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-isoleucinium\n",
      "It is a conjugate acid of a L-isoleucinate\n",
      "It is an enantiomer of a D-isoleucine\n",
      "It is a tautomer of a L-isoleucine zwitterion.\n",
      "\n",
      "Imetit is an imidothiocarbamic ester that consists of isothiourea in which the thiol hydrogen is substituted by a 2-(imidazol-4-yl)ethyl group. An extremely potent, high affinity agonist at H3 and H4 receptors (Ki values are 0.3 and 2.7 nM respectively). Induces shape change in eosinophils with an EC50 of 25 nM. Centrally active following systemic administration. It has a role as a H3-receptor agonist and a H4-receptor agonist. It is a member of imidazoles and an imidothiocarbamic ester. It is a conjugate base of an imetit(2+). \n",
      "\n",
      "Imetit is an imidothiocarbamic ester that consists of isothiourea in which the thiol hydrogen is substituted by a 2-(imidazol-4-yl)ethyl group\n",
      "An extremely potent, high affinity agonist at H3 and H4 receptors (Ki values are 0.3 and 2.7 nM respectively)\n",
      "Induces shape change in eosinophils with an EC50 of 25 nM\n",
      "Centrally active following systemic administration\n",
      "It has a role as a H3-receptor agonist and a H4-receptor agonist\n",
      "It is a member of imidazoles and an imidothiocarbamic ester\n",
      "It is a conjugate base of an imetit(2+).\n",
      "\n",
      "Tyrosine is an alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, a polar amino acid and an aromatic amino acid. It contains a 4-hydroxybenzyl group. It derives from a propionic acid. It is a conjugate base of a tyrosinium. It is a conjugate acid of a tyrosinate(1-). \n",
      "\n",
      "Tyrosine is an alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring\n",
      "It has a role as a Daphnia magna metabolite\n",
      "It is an alpha-amino acid, a polar amino acid and an aromatic amino acid\n",
      "It contains a 4-hydroxybenzyl group\n",
      "It derives from a propionic acid\n",
      "It is a conjugate base of a tyrosinium\n",
      "It is a conjugate acid of a tyrosinate(1-).\n",
      "\n",
      "3-hydroxyanthranilic acid is an aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan. It has a role as a human metabolite and a mouse metabolite. It is an aminobenzoic acid and a monohydroxybenzoic acid. It derives from an anthranilic acid. It is a conjugate acid of a 3-hydroxyanthranilate. It is a tautomer of a 2,3-dihydro-3-oxoanthranilic acid. \n",
      "\n",
      "3-hydroxyanthranilic acid is an aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group\n",
      "It is an intermediate in the metabolism of the amino acid tryptophan\n",
      "It has a role as a human metabolite and a mouse metabolite\n",
      "It is an aminobenzoic acid and a monohydroxybenzoic acid\n",
      "It derives from an anthranilic acid\n",
      "It is a conjugate acid of a 3-hydroxyanthranilate\n",
      "It is a tautomer of a 2,3-dihydro-3-oxoanthranilic acid.\n",
      "\n",
      "Midodrine is an aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine. It has a role as a prodrug, an alpha-adrenergic agonist, a sympathomimetic agent and a vasoconstrictor agent. It is a secondary alcohol, an amino acid amide and an aromatic ether. It derives from a glycinamide and a deglymidodrine. It is a conjugate base of a midodrine(1+). \n",
      "\n",
      "Midodrine is an aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group\n",
      "A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states\n",
      "The main active moiety is its major metabolite, deglymidodrine\n",
      "It has a role as a prodrug, an alpha-adrenergic agonist, a sympathomimetic agent and a vasoconstrictor agent\n",
      "It is a secondary alcohol, an amino acid amide and an aromatic ether\n",
      "It derives from a glycinamide and a deglymidodrine\n",
      "It is a conjugate base of a midodrine(1+).\n",
      "\n",
      "D-tyrosine is an optically active form of tyrosine having D-configuration. It has a role as an Escherichia coli metabolite. It is a tyrosine and a D-alpha-amino acid. It is a conjugate base of a D-tyrosinium. It is a conjugate acid of a D-tyrosinate(1-). It is an enantiomer of a L-tyrosine. It is a tautomer of a D-tyrosine zwitterion. \n",
      "\n",
      "D-tyrosine is an optically active form of tyrosine having D-configuration\n",
      "It has a role as an Escherichia coli metabolite\n",
      "It is a tyrosine and a D-alpha-amino acid\n",
      "It is a conjugate base of a D-tyrosinium\n",
      "It is a conjugate acid of a D-tyrosinate(1-)\n",
      "It is an enantiomer of a L-tyrosine\n",
      "It is a tautomer of a D-tyrosine zwitterion.\n",
      "\n",
      "D-alanine is the D-enantiomer of alanine. It has a role as a human metabolite, an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and an Escherichia coli metabolite. It is a D-alpha-amino acid and an alanine. It is a conjugate base of a D-alaninium. It is a conjugate acid of a D-alaninate. It is an enantiomer of a L-alanine. It is a tautomer of a D-alanine zwitterion. \n",
      "\n",
      "D-alanine is the D-enantiomer of alanine\n",
      "It has a role as a human metabolite, an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and an Escherichia coli metabolite\n",
      "It is a D-alpha-amino acid and an alanine\n",
      "It is a conjugate base of a D-alaninium\n",
      "It is a conjugate acid of a D-alaninate\n",
      "It is an enantiomer of a L-alanine\n",
      "It is a tautomer of a D-alanine zwitterion.\n",
      "\n",
      "Tryptophan is an alpha-amino acid that is alanine bearing an indol-3-yl substituent at position 3. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, an aminoalkylindole, a polar amino acid and an aromatic amino acid. It contains a 1H-indol-3-ylmethyl group. It is a conjugate base of a tryptophanium. It is a conjugate acid of a tryptophanate. It is a tautomer of a tryptophan zwitterion. \n",
      "\n",
      "Tryptophan is an alpha-amino acid that is alanine bearing an indol-3-yl substituent at position 3\n",
      "It has a role as a Daphnia magna metabolite\n",
      "It is an alpha-amino acid, an aminoalkylindole, a polar amino acid and an aromatic amino acid\n",
      "It contains a 1H-indol-3-ylmethyl group\n",
      "It is a conjugate base of a tryptophanium\n",
      "It is a conjugate acid of a tryptophanate\n",
      "It is a tautomer of a tryptophan zwitterion.\n",
      "\n",
      "L-asparagine is an optically active form of asparagine having L-configuration. It has a role as a nutraceutical, a micronutrient, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and a plant metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, an asparagine and a L-alpha-amino acid. It is a conjugate base of a L-asparaginium. It is a conjugate acid of a L-asparaginate. It is an enantiomer of a D-asparagine. It is a tautomer of a L-asparagine zwitterion. \n",
      "\n",
      "L-asparagine is an optically active form of asparagine having L-configuration\n",
      "It has a role as a nutraceutical, a micronutrient, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and a plant metabolite\n",
      "It is an aspartate family amino acid, a proteinogenic amino acid, an asparagine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-asparaginium\n",
      "It is a conjugate acid of a L-asparaginate\n",
      "It is an enantiomer of a D-asparagine\n",
      "It is a tautomer of a L-asparagine zwitterion.\n",
      "\n",
      "Mycophenolic acid is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. It has a role as an antineoplastic agent, an antimicrobial agent, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor, an immunosuppressive agent, a mycotoxin, a Penicillium metabolite, an environmental contaminant, a xenobiotic and an anticoronaviral agent. It is a gamma-lactone, a member of phenols, a monocarboxylic acid and a member of 2-benzofurans. It derives from a hex-4-enoic acid. It is a conjugate acid of a mycophenolate. \n",
      "\n",
      "Mycophenolic acid is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively\n",
      "It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species\n",
      "An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases\n",
      "It has a role as an antineoplastic agent, an antimicrobial agent, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor, an immunosuppressive agent, a mycotoxin, a Penicillium metabolite, an environmental contaminant, a xenobiotic and an anticoronaviral agent\n",
      "It is a gamma-lactone, a member of phenols, a monocarboxylic acid and a member of 2-benzofurans\n",
      "It derives from a hex-4-enoic acid\n",
      "It is a conjugate acid of a mycophenolate.\n",
      "\n",
      "TMC-52C is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-phenylalaninamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52C acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 460 nM, 10 nM, and 88 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S). It has a role as an antimicrobial agent, a cathepsin B inhibitor, a cathepsin L (EC 3.4.22.15) inhibitor, an EC 3.4.22.2 (papain) inhibitor and a fungal metabolite. It is an epoxide, a monocarboxylic acid, a primary amino compound, a secondary amino compound and a dicarboxylic acid monoamide. \n",
      "\n",
      "TMC-52C is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-phenylalaninamide\n",
      "It is a natural product, isolated from Gliocladium sp\n",
      "F-2665\n",
      "TMC-52C acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 460 nM, 10 nM, and 88 nM, respectively\n",
      "The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S)\n",
      "It has a role as an antimicrobial agent, a cathepsin B inhibitor, a cathepsin L (EC 3.4.22.15) inhibitor, an EC 3.4.22.2 (papain) inhibitor and a fungal metabolite\n",
      "It is an epoxide, a monocarboxylic acid, a primary amino compound, a secondary amino compound and a dicarboxylic acid monoamide.\n",
      "\n",
      "(R)-lipoic acid is the (R)-enantiomer of lipoic acid. A vitamin-like, C8 thia fatty acid with anti-oxidant properties. It has a role as a prosthetic group, a nutraceutical and a cofactor. It is a lipoic acid, a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It derives from an octanoic acid. It is a conjugate acid of a (R)-lipoate. It is an enantiomer of a (S)-lipoic acid. \n",
      "\n",
      "(R)-lipoic acid is the (R)-enantiomer of lipoic acid\n",
      "A vitamin-like, C8 thia fatty acid with anti-oxidant properties\n",
      "It has a role as a prosthetic group, a nutraceutical and a cofactor\n",
      "It is a lipoic acid, a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid\n",
      "It derives from an octanoic acid\n",
      "It is a conjugate acid of a (R)-lipoate\n",
      "It is an enantiomer of a (S)-lipoic acid.\n",
      "\n",
      "Methiothepin is a dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively). It has a role as an antipsychotic agent, a dopaminergic antagonist and a serotonergic antagonist. It is a N-alkylpiperazine, a dibenzothiepine, an aryl sulfide and a tertiary amino compound. It is a conjugate base of a methiothepin(2+). \n",
      "\n",
      "Methiothepin is a dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively\n",
      "Potent 5-HT2 antagonist, also active as 5-HT1 antagonist\n",
      "Differentiates 5-HT1D sub-types\n",
      "Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively)\n",
      "It has a role as an antipsychotic agent, a dopaminergic antagonist and a serotonergic antagonist\n",
      "It is a N-alkylpiperazine, a dibenzothiepine, an aryl sulfide and a tertiary amino compound\n",
      "It is a conjugate base of a methiothepin(2+).\n",
      "\n",
      "WIN 18446 is a carboxamide that is 1,8-diaminooctane in which a hydrogen attached to each of the amino groups has been replaced by a dichloroacetyl group. Inhibitor of aldehyde dehydrogenase 1a2 (ALDH1a2). Inhibits the biosynthesis of retinoic acid from retinol in neonatal and adult murine testis. It down-regulates sex related genes in zebrafish. It has a role as an EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor. It is an organochlorine compound and a secondary carboxamide. It derives from a dichloroacetic acid and a 1,8-diaminooctane. \n",
      "\n",
      "WIN 18446 is a carboxamide that is 1,8-diaminooctane in which a hydrogen attached to each of the amino groups has been replaced by a dichloroacetyl group\n",
      "Inhibitor of aldehyde dehydrogenase 1a2 (ALDH1a2)\n",
      "Inhibits the biosynthesis of retinoic acid from retinol in neonatal and adult murine testis\n",
      "It down-regulates sex related genes in zebrafish\n",
      "It has a role as an EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor\n",
      "It is an organochlorine compound and a secondary carboxamide\n",
      "It derives from a dichloroacetic acid and a 1,8-diaminooctane.\n",
      "\n",
      "L-phenylalanine is the L-enantiomer of phenylalanine. It has a role as a nutraceutical, a micronutrient, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, an algal metabolite, a mouse metabolite, a human xenobiotic metabolite and an EC 3.1.3.1 (alkaline phosphatase) inhibitor. It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a phenylalanine and a L-alpha-amino acid. It is a conjugate base of a L-phenylalaninium. It is a conjugate acid of a L-phenylalaninate. It is an enantiomer of a D-phenylalanine. It is a tautomer of a L-phenylalanine zwitterion. \n",
      "\n",
      "L-phenylalanine is the L-enantiomer of phenylalanine\n",
      "It has a role as a nutraceutical, a micronutrient, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, an algal metabolite, a mouse metabolite, a human xenobiotic metabolite and an EC 3.1.3.1 (alkaline phosphatase) inhibitor\n",
      "It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a phenylalanine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-phenylalaninium\n",
      "It is a conjugate acid of a L-phenylalaninate\n",
      "It is an enantiomer of a D-phenylalanine\n",
      "It is a tautomer of a L-phenylalanine zwitterion.\n",
      "\n",
      "L-alanine is the L-enantiomer of alanine. It has a role as an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and a fundamental metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and an alanine. It is a conjugate base of a L-alaninium. It is a conjugate acid of a L-alaninate. It is an enantiomer of a D-alanine. It is a tautomer of a L-alanine zwitterion. \n",
      "\n",
      "L-alanine is the L-enantiomer of alanine\n",
      "It has a role as an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and a fundamental metabolite\n",
      "It is a pyruvate family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and an alanine\n",
      "It is a conjugate base of a L-alaninium\n",
      "It is a conjugate acid of a L-alaninate\n",
      "It is an enantiomer of a D-alanine\n",
      "It is a tautomer of a L-alanine zwitterion.\n",
      "\n",
      "Carmoxirole is an indolecarboxylic acid that is indole-5-carboxylic acid bearing an additional 4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl substituent at position 3. Selective, peripherally acting dopamine D2 receptor agonist. Modulates noradrenalin release and sympathetic activation. Displays antihypertensive properties in vivo. It has a role as an antihypertensive agent, a dopamine agonist and a platelet aggregation inhibitor. It is an indolecarboxylic acid, a tetrahydropyridine and a tertiary amino compound. It is a conjugate base of a carmoxirole(1+). \n",
      "\n",
      "Carmoxirole is an indolecarboxylic acid that is indole-5-carboxylic acid bearing an additional 4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl substituent at position 3\n",
      "Selective, peripherally acting dopamine D2 receptor agonist\n",
      "Modulates noradrenalin release and sympathetic activation\n",
      "Displays antihypertensive properties in vivo\n",
      "It has a role as an antihypertensive agent, a dopamine agonist and a platelet aggregation inhibitor\n",
      "It is an indolecarboxylic acid, a tetrahydropyridine and a tertiary amino compound\n",
      "It is a conjugate base of a carmoxirole(1+).\n",
      "\n",
      "Thiocyclam is an organosulfur heterocyclic compound that is 1,2,3-trithiane in which one of the hydrogens at position 5 has been replaced by a dimethylamino group. A nicotinic acetylcholine receptor agonist, it was used (particularly as its hydrogen oxalate salt, known as thyocyclam oxalate) as a broad-spectrum insecticide, but it is also toxic to bees, fish and other aquatic organisms. It is not approved for use within the European Union. It has a role as an agrochemical and a nicotinic acetylcholine receptor agonist. It is a nereistoxin analogue insecticide and an organosulfur heterocyclic compound. It is a conjugate base of a thiocyclam(1+). It derives from a hydride of a 1,2,3-trithiane. \n",
      "\n",
      "Thiocyclam is an organosulfur heterocyclic compound that is 1,2,3-trithiane in which one of the hydrogens at position 5 has been replaced by a dimethylamino group\n",
      "A nicotinic acetylcholine receptor agonist, it was used (particularly as its hydrogen oxalate salt, known as thyocyclam oxalate) as a broad-spectrum insecticide, but it is also toxic to bees, fish and other aquatic organisms\n",
      "It is not approved for use within the European Union\n",
      "It has a role as an agrochemical and a nicotinic acetylcholine receptor agonist\n",
      "It is a nereistoxin analogue insecticide and an organosulfur heterocyclic compound\n",
      "It is a conjugate base of a thiocyclam(1+)\n",
      "It derives from a hydride of a 1,2,3-trithiane.\n",
      "\n",
      "Serine is an alpha-amino acid that is alanine substituted at position 3 by a hydroxy group. It has a role as a fundamental metabolite. It is an alpha-amino acid and a polar amino acid. It contains a hydroxymethyl group. It is a conjugate base of a serinium. It is a conjugate acid of a serinate. It is a tautomer of a serine zwitterion. \n",
      "\n",
      "Serine is an alpha-amino acid that is alanine substituted at position 3 by a hydroxy group\n",
      "It has a role as a fundamental metabolite\n",
      "It is an alpha-amino acid and a polar amino acid\n",
      "It contains a hydroxymethyl group\n",
      "It is a conjugate base of a serinium\n",
      "It is a conjugate acid of a serinate\n",
      "It is a tautomer of a serine zwitterion.\n",
      "\n",
      "(-)-echitovenine(1+) is an ammonium ion resulting from the protonation of the tertiary amino group of (-)-echitovenine. The major species at pH 7.3. Note the stereoconfiguration of the 19 hydroxy group is based on CHEBI:144373 (and Fig. S10). It is an ammonium ion derivative and an indole alkaloid cation. It is a conjugate acid of a (-)-echitovenine. It is an enantiomer of a (+)-echitovenine(1+). \n",
      "\n",
      "(-)-echitovenine(1+) is an ammonium ion resulting from the protonation of the tertiary amino group of (-)-echitovenine\n",
      "The major species at pH 7.3\n",
      "Note the stereoconfiguration of the 19 hydroxy group is based on CHEBI:144373 (and Fig\n",
      "S10)\n",
      "It is an ammonium ion derivative and an indole alkaloid cation\n",
      "It is a conjugate acid of a (-)-echitovenine\n",
      "It is an enantiomer of a (+)-echitovenine(1+).\n",
      "\n",
      "D-proline is the D-enantiomer of proline. It has a role as a mouse metabolite. It is a D-alpha-amino acid and a proline. It is a conjugate base of a D-prolinium. It is a conjugate acid of a D-prolinate. It is an enantiomer of a L-proline. It is a tautomer of a D-proline zwitterion. \n",
      "\n",
      "D-proline is the D-enantiomer of proline\n",
      "It has a role as a mouse metabolite\n",
      "It is a D-alpha-amino acid and a proline\n",
      "It is a conjugate base of a D-prolinium\n",
      "It is a conjugate acid of a D-prolinate\n",
      "It is an enantiomer of a L-proline\n",
      "It is a tautomer of a D-proline zwitterion.\n",
      "\n",
      "L-leucine is the L-enantiomer of leucine. It has a role as a plant metabolite, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a leucine and a L-alpha-amino acid. It is a conjugate base of a L-leucinium. It is a conjugate acid of a L-leucinate. It is an enantiomer of a D-leucine. It is a tautomer of a L-leucine zwitterion. \n",
      "\n",
      "L-leucine is the L-enantiomer of leucine\n",
      "It has a role as a plant metabolite, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a human metabolite, an algal metabolite and a mouse metabolite\n",
      "It is a pyruvate family amino acid, a proteinogenic amino acid, a leucine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-leucinium\n",
      "It is a conjugate acid of a L-leucinate\n",
      "It is an enantiomer of a D-leucine\n",
      "It is a tautomer of a L-leucine zwitterion.\n",
      "\n",
      "4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide is a benzamide obtained by formal condensation of the carboxy group of 4-fluorobenzoic acid with the primary amino group of 2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethylamine. Highly potent selective 5-HT1A receptor full agonist (pKi values are 9.0, 6.6, 7.5, 6.6 and < 6.0 for 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 receptors respectively). Possibly binds between the agonist binding site and the G protein interaction switch site, affecting the activation mechanism, and may display positive cooperativity. Anxiolytic following central administration in vivo. It has a role as an anxiolytic drug and a serotonergic agonist. It is a N-arylpiperazine, a N-alkylpiperazine, a methoxynaphthalene, a member of benzamides and an organofluorine compound. It is a conjugate base of a 4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide(1+). \n",
      "\n",
      "4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide is a benzamide obtained by formal condensation of the carboxy group of 4-fluorobenzoic acid with the primary amino group of 2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethylamine\n",
      "Highly potent selective 5-HT1A receptor full agonist (pKi values are 9.0, 6.6, 7.5, 6.6 and < 6.0 for 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 receptors respectively)\n",
      "Possibly binds between the agonist binding site and the G protein interaction switch site, affecting the activation mechanism, and may display positive cooperativity\n",
      "Anxiolytic following central administration in vivo\n",
      "It has a role as an anxiolytic drug and a serotonergic agonist\n",
      "It is a N-arylpiperazine, a N-alkylpiperazine, a methoxynaphthalene, a member of benzamides and an organofluorine compound\n",
      "It is a conjugate base of a 4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide(1+).\n",
      "\n",
      "L-valine is the L-enantiomer of valine. It has a role as a nutraceutical, a micronutrient, a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a valine and a L-alpha-amino acid. It is a conjugate base of a L-valinium. It is a conjugate acid of a L-valinate. It is an enantiomer of a D-valine. It is a tautomer of a L-valine zwitterion. \n",
      "\n",
      "L-valine is the L-enantiomer of valine\n",
      "It has a role as a nutraceutical, a micronutrient, a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite\n",
      "It is a pyruvate family amino acid, a proteinogenic amino acid, a valine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-valinium\n",
      "It is a conjugate acid of a L-valinate\n",
      "It is an enantiomer of a D-valine\n",
      "It is a tautomer of a L-valine zwitterion.\n",
      "\n",
      "Sumatriptan is a sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults. It has a role as a serotonergic agonist and a vasoconstrictor agent. It is a sulfonamide and a member of tryptamines. It derives from a N,N-dimethyltryptamine. It is a conjugate acid of a sumatriptan(1+). \n",
      "\n",
      "Sumatriptan is a sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5\n",
      "Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family)\n",
      "Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults\n",
      "It has a role as a serotonergic agonist and a vasoconstrictor agent\n",
      "It is a sulfonamide and a member of tryptamines\n",
      "It derives from a N,N-dimethyltryptamine\n",
      "It is a conjugate acid of a sumatriptan(1+).\n",
      "\n",
      "(R)-3-hydroxybutyric acid is the R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis. It has a role as a human metabolite, a pheromone and a fungal metabolite. It is a ketone body and a 3-hydroxybutyric acid. It is a conjugate acid of a (R)-3-hydroxybutyrate. It is an enantiomer of a (S)-3-hydroxybutyric acid. \n",
      "\n",
      "(R)-3-hydroxybutyric acid is the R-enantiomer of 3-hydroxybutyric acid\n",
      "Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics\n",
      "It is a sex pheremone in the European spider Linyphia triangularis\n",
      "It has a role as a human metabolite, a pheromone and a fungal metabolite\n",
      "It is a ketone body and a 3-hydroxybutyric acid\n",
      "It is a conjugate acid of a (R)-3-hydroxybutyrate\n",
      "It is an enantiomer of a (S)-3-hydroxybutyric acid.\n",
      "\n",
      "L-tryptophan is the L-enantiomer of tryptophan. It has a role as an antidepressant, a nutraceutical, a micronutrient, a plant metabolite, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a tryptophan and a L-alpha-amino acid. It is a conjugate base of a L-tryptophanium. It is a conjugate acid of a L-tryptophanate. It is an enantiomer of a D-tryptophan. It is a tautomer of a L-tryptophan zwitterion. \n",
      "\n",
      "L-tryptophan is the L-enantiomer of tryptophan\n",
      "It has a role as an antidepressant, a nutraceutical, a micronutrient, a plant metabolite, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite\n",
      "It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a tryptophan and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-tryptophanium\n",
      "It is a conjugate acid of a L-tryptophanate\n",
      "It is an enantiomer of a D-tryptophan\n",
      "It is a tautomer of a L-tryptophan zwitterion.\n",
      "\n",
      "Diclocymet is a diastereoisomeric mixture comprising equimolar amounts of (1R,2S)- and (1R,2R)-diclocymet. A fungicide used for the control of rice blast in paddy fields. It also shows some activity against paddy field insect pests including rice water weevil and rice-stem borer. Diclocymet is moderately toxic to fish. It has a role as a xenobiotic, an insecticide, a melanin synthesis inhibitor and an antifungal agrochemical. It is a diastereoisomeric mixture and an amide fungicide. It contains a (1R,2S)-diclocymet and a (1R,2R)-diclocymet. \n",
      "\n",
      "Diclocymet is a diastereoisomeric mixture comprising equimolar amounts of (1R,2S)- and (1R,2R)-diclocymet\n",
      "A fungicide used for the control of rice blast in paddy fields\n",
      "It also shows some activity against paddy field insect pests including rice water weevil and rice-stem borer\n",
      "Diclocymet is moderately toxic to fish\n",
      "It has a role as a xenobiotic, an insecticide, a melanin synthesis inhibitor and an antifungal agrochemical\n",
      "It is a diastereoisomeric mixture and an amide fungicide\n",
      "It contains a (1R,2S)-diclocymet and a (1R,2R)-diclocymet.\n",
      "\n",
      "Morphine is a morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). It has a role as an opioid analgesic, a mu-opioid receptor agonist, a plant metabolite, an environmental contaminant, a xenobiotic, a vasodilator agent, an anaesthetic and a drug allergen. It is an organic heteropentacyclic compound, a tertiary amino compound and a morphinane alkaloid. It is a conjugate base of a morphine(1+). It derives from a hydride of a morphinan. \n",
      "\n",
      "Morphine is a morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug\n",
      "Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly\n",
      "Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy)\n",
      "It has a role as an opioid analgesic, a mu-opioid receptor agonist, a plant metabolite, an environmental contaminant, a xenobiotic, a vasodilator agent, an anaesthetic and a drug allergen\n",
      "It is an organic heteropentacyclic compound, a tertiary amino compound and a morphinane alkaloid\n",
      "It is a conjugate base of a morphine(1+)\n",
      "It derives from a hydride of a morphinan.\n",
      "\n",
      "Se-methyl-L-selenocysteine is an L-alpha-amino acid compound having methylselanylmethyl as the side-chain. It has a role as an antineoplastic agent. It is a Se-methylselenocysteine, a non-proteinogenic L-alpha-amino acid and a L-selenocysteine derivative. It is a conjugate base of a Se-methyl-L-selenocysteinium. It is a conjugate acid of a Se-methyl-L-selenocysteinate. It is an enantiomer of a Se-methyl-D-selenocysteine. It is a tautomer of a Se-methyl-L-selenocysteine zwitterion. \n",
      "\n",
      "Se-methyl-L-selenocysteine is an L-alpha-amino acid compound having methylselanylmethyl as the side-chain\n",
      "It has a role as an antineoplastic agent\n",
      "It is a Se-methylselenocysteine, a non-proteinogenic L-alpha-amino acid and a L-selenocysteine derivative\n",
      "It is a conjugate base of a Se-methyl-L-selenocysteinium\n",
      "It is a conjugate acid of a Se-methyl-L-selenocysteinate\n",
      "It is an enantiomer of a Se-methyl-D-selenocysteine\n",
      "It is a tautomer of a Se-methyl-L-selenocysteine zwitterion.\n",
      "\n",
      "4-hydroxyphenyl retinamide is a retinoid obtained by formal condensation of the carboxy group of all-trans retinoic acid and the anilino group of 4-hydroxyaniline. Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo. Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids. It has a role as an antineoplastic agent and an antioxidant. It is a retinoid and a monocarboxylic acid amide. It derives from an all-trans-retinoic acid. \n",
      "\n",
      "4-hydroxyphenyl retinamide is a retinoid obtained by formal condensation of the carboxy group of all-trans retinoic acid and the anilino group of 4-hydroxyaniline\n",
      "Synthetic retinoid agonist\n",
      "Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo\n",
      "Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids\n",
      "It has a role as an antineoplastic agent and an antioxidant\n",
      "It is a retinoid and a monocarboxylic acid amide\n",
      "It derives from an all-trans-retinoic acid.\n",
      "\n",
      "CGP 78608 is a phosphonic acid in which the hydrogen attached to phosphorous is substituted by a 1-{[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]amino}ethyl group. Potent and selective NMDA antagonist that acts through the glycine site (IC50 = 5 nM). Displays >500-fold selectivity over kainate and AMPA receptors (IC50 values are 2.7 and 3 muM respectively). Anticonvulsant in vivo following systemic administration. It has a role as a NMDA receptor antagonist and an anticonvulsant. It is a quinoxaline derivative, an organobromine compound, a secondary amino compound and a member of phosphonic acids. It contains a CGP 78608(1+). \n",
      "\n",
      "CGP 78608 is a phosphonic acid in which the hydrogen attached to phosphorous is substituted by a 1-{[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]amino}ethyl group\n",
      "Potent and selective NMDA antagonist that acts through the glycine site (IC50 = 5 nM)\n",
      "Displays >500-fold selectivity over kainate and AMPA receptors (IC50 values are 2.7 and 3 muM respectively)\n",
      "Anticonvulsant in vivo following systemic administration\n",
      "It has a role as a NMDA receptor antagonist and an anticonvulsant\n",
      "It is a quinoxaline derivative, an organobromine compound, a secondary amino compound and a member of phosphonic acids\n",
      "It contains a CGP 78608(1+).\n",
      "\n",
      "6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator. It has a role as an antifibrinolytic drug, a hematologic agent and a metabolite. It is an epsilon-amino acid and an omega-amino fatty acid. It derives from a hexanoic acid. It is a conjugate acid of a 6-aminohexanoate. It is a tautomer of a 6-aminohexanoic acid zwitterion. \n",
      "\n",
      "6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6\n",
      "Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator\n",
      "It has a role as an antifibrinolytic drug, a hematologic agent and a metabolite\n",
      "It is an epsilon-amino acid and an omega-amino fatty acid\n",
      "It derives from a hexanoic acid\n",
      "It is a conjugate acid of a 6-aminohexanoate\n",
      "It is a tautomer of a 6-aminohexanoic acid zwitterion.\n",
      "\n",
      "Ascr#10 is an (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (8R)-8-hydroxynonanoic acid with ascarylopyranose (the alpha anomer). A metabolite of the nematode Caenorhabditis elegans, it is the direct biosynthetic precursor to ascr#3. It has also been detected in the sour paste nematode, Panagrellus redivivus. It has a role as a Caenorhabditis elegans metabolite. It is a monocarboxylic acid and an (omega-1)-hydroxy fatty acid ascaroside. It derives from an (8R)-8-hydroxynonanoic acid. It is a conjugate acid of an ascr#10(1-). \n",
      "\n",
      "Ascr#10 is an (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (8R)-8-hydroxynonanoic acid with ascarylopyranose (the alpha anomer)\n",
      "A metabolite of the nematode Caenorhabditis elegans, it is the direct biosynthetic precursor to ascr#3\n",
      "It has also been detected in the sour paste nematode, Panagrellus redivivus\n",
      "It has a role as a Caenorhabditis elegans metabolite\n",
      "It is a monocarboxylic acid and an (omega-1)-hydroxy fatty acid ascaroside\n",
      "It derives from an (8R)-8-hydroxynonanoic acid\n",
      "It is a conjugate acid of an ascr#10(1-).\n",
      "\n",
      "Methoxsalen is a member of the class of psoralens that is 7H-furo[3,2-g]chromen-7-one in which the 9 position is substituted by a methoxy group. It is a constituent of the fruits of Ammi majus. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered topically or orally in conjunction with UV-A for phototherapy treatment of vitiligo and severe psoriasis. It has a role as a dermatologic drug, an antineoplastic agent, a photosensitizing agent, a cross-linking reagent and a plant metabolite. It is a member of psoralens and an aromatic ether. It derives from a psoralen. \n",
      "\n",
      "Methoxsalen is a member of the class of psoralens that is 7H-furo[3,2-g]chromen-7-one in which the 9 position is substituted by a methoxy group\n",
      "It is a constituent of the fruits of Ammi majus\n",
      "Like other psoralens, trioxsalen causes photosensitization of the skin\n",
      "It is administered topically or orally in conjunction with UV-A for phototherapy treatment of vitiligo and severe psoriasis\n",
      "It has a role as a dermatologic drug, an antineoplastic agent, a photosensitizing agent, a cross-linking reagent and a plant metabolite\n",
      "It is a member of psoralens and an aromatic ether\n",
      "It derives from a psoralen.\n",
      "\n",
      "Sarcosine is a N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine. It has a role as a glycine transporter 1 inhibitor, a glycine receptor agonist, a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a N-alkylglycine, a N-methyl-amino acid and a member of N-methylglycines. It is a conjugate base of a sarcosinium. It is a conjugate acid of a sarcosinate. It is a tautomer of a sarcosine zwitterion. \n",
      "\n",
      "Sarcosine is a N-alkylglycine that is the N-methyl derivative of glycine\n",
      "It is an intermediate in the metabolic pathway of glycine\n",
      "It has a role as a glycine transporter 1 inhibitor, a glycine receptor agonist, a human metabolite, an Escherichia coli metabolite and a mouse metabolite\n",
      "It is a N-alkylglycine, a N-methyl-amino acid and a member of N-methylglycines\n",
      "It is a conjugate base of a sarcosinium\n",
      "It is a conjugate acid of a sarcosinate\n",
      "It is a tautomer of a sarcosine zwitterion.\n",
      "\n",
      "L-selenocysteine is the L-enantiomer of selenocysteine. It has a role as a human metabolite. It is a L-alpha-amino acid, a selenocysteine, a proteinogenic amino acid and a L-alanine derivative. It is a conjugate base of a L-selenocysteinium. It is a conjugate acid of a L-selenocysteinate(1-). It is an enantiomer of a D-selenocysteine. It is a tautomer of a L-selenocysteine zwitterion. \n",
      "\n",
      "L-selenocysteine is the L-enantiomer of selenocysteine\n",
      "It has a role as a human metabolite\n",
      "It is a L-alpha-amino acid, a selenocysteine, a proteinogenic amino acid and a L-alanine derivative\n",
      "It is a conjugate base of a L-selenocysteinium\n",
      "It is a conjugate acid of a L-selenocysteinate(1-)\n",
      "It is an enantiomer of a D-selenocysteine\n",
      "It is a tautomer of a L-selenocysteine zwitterion.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Print the texts with the length equal to 6\n",
    "for i in range(len(split_texts)):\n",
    "    if len(split_texts[i]) == 7:\n",
    "        print(texts[i], \"\\n\")\n",
    "        spt = split_texts[i]\n",
    "        for s in spt:\n",
    "            print(s)\n",
    "        print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Phenyl salicylate is a benzoate ester that is the phenyl ester of salicylic acid\n",
      "Also known as salol, it can be formed by heating salicylic acid with phenol and is used in the manufacture of some polymers, lacquers, adhesives, waxes and polishes\n",
      "It has a role as an ultraviolet filter\n",
      "It is a benzoate ester, a member of phenols and a member of salicylates\n",
      "It derives from a salicylic acid.\n",
      "\n",
      "BMS-754807 is a pyrrolotriazine that is pyrrolo[2,1-f][1,2,4]triazine which is substituted at position 2 by the pyrrolidine nitrogen of (2S)-N-(6-fluoropyridin-3-yl)-2-methylprolinamide, and at position 4 by a (5-cyclopropyl-1H-pyrazol-3-yl)amino group\n",
      "It is a potent, reversible inhibitor of the insulin-like growth factor 1 receptor/insulin receptor family kinases\n",
      "It has a role as an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an antineoplastic agent\n",
      "It is a pyrrolotriazine, a member of pyrazoles, a member of pyridines and a member of pyrrolidines.\n",
      "\n",
      "Robinin is a glycosyloxyflavone that is kaempherol substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-galactopyranosyl residue at position 3 and a 6-deoxy-alpha-L-mannopyranosyl residue at position 7 via a glycosidic linkage\n",
      "It has a role as a plant metabolite\n",
      "It is a glycosyloxyflavone and a dihydroxyflavone\n",
      "It derives from a kaempferol.\n",
      "\n",
      "5-O-sinapoylquinic acid is a cinnamate ester obtained by formal condensation of the carboxy group of sinapic acid with the 5-hydroxy group of (-)-quinic acid\n",
      "It has a role as a metabolite\n",
      "It is a cinnamate ester and a cyclitol carboxylic acid\n",
      "It derives from a (-)-quinic acid and a trans-sinapic acid.\n",
      "\n",
      "L-arabino-1,4-lactone-5-phosphate is a aldonolactone phosphate that is L-arabino-1,4-lactone carrying a single phospho substituent at position 5\n",
      "It is a gamma-lactone and an aldonolactone phosphate\n",
      "It derives from a L-arabinono-1,4-lactone\n",
      "It is a conjugate acid of a L-arabino-1,4-lactone-5-phosphate(2-).\n",
      "\n",
      "1-arachidonoyl-sn-glycerol 3-phosphate is a 1-acyl-sn-glycerol 3-phosphate in which the 1-O-acyl group is specified as arachidonoyl\n",
      "It has a role as a metabolite\n",
      "It derives from an arachidonic acid\n",
      "It is a conjugate base of a 1-arachidonoyl-sn-glycerol 3-phosphate(2-).\n",
      "\n",
      "Emodin is a trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6\n",
      "It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens\n",
      "It is an active ingredient of various Chinese herbs\n",
      "It has a role as a tyrosine kinase inhibitor, an antineoplastic agent, a laxative and a plant metabolite\n",
      "It derives from an emodin anthrone\n",
      "It is a conjugate acid of an emodin(1-).\n",
      "\n",
      "Glu-Glu-Gly is a tripeptide composed of two L-glutamic acid and one glycine residues joined in sequence\n",
      "It has a role as a metabolite\n",
      "It derives from a L-glutamic acid and a glycine.\n",
      "\n",
      "Alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->2)-alpha-D-Manp-(1->2)-alpha-D-Manp-(1->6)]-alpha-D-Manp is a mannopentaose comprised of an linear chain of four alpha-D-mannose residues, linked sequentially (1->2), (1->2) and (1->6), to the reducing-end residue of which is also linked (1->3) a fifth alpha-D-mannose\n",
      "It has a role as an epitope.\n",
      "\n",
      "Alpha-D-galactose 1-phosphate(2-) is an organophosphate oxoanion arising from deprotonation of the phosphate OH groups of alpha-D-galactose 1-phosphate; major species at pH 7.3\n",
      "It has a role as a human metabolite and a Saccharomyces cerevisiae metabolite\n",
      "It is an organophosphate oxoanion and a monosaccharide 1-phosphate(2-)\n",
      "It is a conjugate base of an alpha-D-galactose 1-phosphate\n",
      "It is an enantiomer of an alpha-L-galactose 1-phosphate(2-).\n",
      "\n",
      "Glutaramate is a monocarboxylic acid anion that is obtained by removal of a proton from the carboxylic acid group of glutaramic acid\n",
      "It is a conjugate base of a glutaramic acid.\n",
      "\n",
      "Delta(1),Delta(7)-dafachronic acid is a member of the class of dafachronic acids that is (25S)-5alpha-cholestan-26-oic acid which is substituted at position 3 by an oxo group and which contains double bonds at the 1-2 and 7-8 positions\n",
      "Found in Caenorhabditis elegans\n",
      "It has a role as a Caenorhabditis elegans metabolite\n",
      "It is a member of dafachronic acids, a 3-oxo-Delta(1) steroid and a 3-oxo Delta(7)-steroid.\n",
      "\n",
      "Acetaminophen O-beta-D-glucosiduronate is a beta-D-glucosiduronate that is the conjugate base of acetaminophen O-beta-D-glucosiduronic acid, obtained by deprotonation of the carboxy group\n",
      "It is a conjugate base of an acetaminophen O-beta-D-glucosiduronic acid.\n",
      "\n",
      "Alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-GlcNAc is an amino trisaccharide consisting of two D-galactose residues and an N-acetyl-D-glucosamine residue (at the reducing end) in a linear sequence\n",
      "It is an amino trisaccharide and a glucosamine oligosaccharide.\n",
      "\n",
      "L-Lys-D-Asp is a dipeptide obtained by formal condensation of the carboxy group of L-lysine with the amino group of D-aspartic acid\n",
      "It is a constituent of bacterial peptidoglycan type A4alpha\n",
      "It derives from a D-aspartic acid and a L-lysine.\n",
      "\n",
      "8-geranylesculetin is a member of the class of hydroxycoumarins that is esculetin in which the ring hydrogen at position 8 has been replaced by a geranyl group\n",
      "It is a hydroxycoumarin and a monoterpenoid\n",
      "It derives from an esculetin.\n",
      "\n",
      "(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate is a hydroxydocosapentaenoate that is the conjugate base of (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid, arising from deprotonation of the carboxy group; major species at pH 7.3\n",
      "It is a conjugate base of a (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid.\n",
      "\n",
      "Isoprene is a hemiterpene with the formula CH2=C(CH3)CH=CH2; the monomer of natural rubber and a common structure motif to the isoprenoids, a large class of other naturally occurring compounds\n",
      "It has a role as a plant metabolite\n",
      "It is an alkadiene, a hemiterpene and a volatile organic compound.\n",
      "\n",
      "Myricetin 3-O-[(6-O-trans-4-coumaroyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside] is a glycosyloxyflavone that is myricetin 3-O-[beta-D-glucosyl-(1->2)-alpha-L-rhamnoside] in which the terminal glucose residue has been esterified at position 6 by formal condensation with 4-coumaric acid\n",
      "Identified in Fig\n",
      "S21 of PMID:29967287\n",
      "It is a pentahydroxyflavone, a cinnamate ester, a disaccharide derivative and a glycosyloxyflavone\n",
      "It derives from a myricetin and a trans-4-coumaric acid\n",
      "It is a conjugate acid of a myricetin 3-O-[(6-O-trans-4-coumaroyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside](2-).\n",
      "\n",
      "N-stearoylhexadecasphinganine is an N-acylhexadecasphinganine in which the acyl group is specified as stearoyl (octadecanoyl)\n",
      "It is a N-acylhexadecasphinganine and a Cer(d34:0)\n",
      "It derives from an octadecanoic acid.\n",
      "\n",
      "(2S)-ibuprofenoyl-CoA(4-) is an acyl-CoA(4-) resulting from the removal of all four protons from the phosphate and diphosphate groups of (2S)-ibuprofenoyl-CoA; major species at pH 7.3.\n",
      "\n",
      "N-cyclohexyl-4-(imidazo[1,2-a]pyridin-3-yl)-N-methylpyrimidin-2-amine is an aminopyrimidine that is N-cyclohexyl-N-methylpyrimidin-2-amine in which the pyrimidine ring is substituted at position 4 by an imidazo[1,2-a]pyridin-3-yl group\n",
      "It is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4; EC 2.7.11.1)\n",
      "It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor\n",
      "It is an imidazopyridine and an aminopyrimidine.\n",
      "\n",
      "Butan-1-ol is a primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group\n",
      "It it produced in small amounts in humans by the gut microbes\n",
      "It has a role as a protic solvent, a human metabolite and a mouse metabolite\n",
      "It is a primary alcohol and an alkyl alcohol.\n",
      "\n",
      "(S)-mecoprop is the (S)-enantiomer of 2-(4-chloro-2-methylphenoxy)propanoic acid; the inactive stereoisomer of the racemic herbicide mecoprop\n",
      "It is a conjugate acid of a (S)-2-(4-chloro-2-methylphenoxy)propanoate\n",
      "It is an enantiomer of a (R)-mecoprop.\n",
      "\n",
      "1-hexadecanoyl-2-[(9Z)-octadecenoyl]-3-[(11Z)-icosenoyl]-sn-glycerol is a triacyl-sn-glycerol in which the which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, (9Z)-octadecenoyl and (11Z)-icosenoyl respectively\n",
      "It has a role as a human blood serum metabolite\n",
      "It is a triacyl-sn-glycerol and a triacylglycerol 54:2.\n",
      "\n",
      "Alpha-D-ribose 1-methylphosphonate 5-triphosphate(5-) is an organophosphate oxoanion obtained by deprotonation of the triphosphate and phosphonate OH groups of alpha-D-ribose 1-methylphosphonate 5-triphosphate\n",
      "It is an organophosphate oxoanion and an organophosphonate oxoanion\n",
      "It is a conjugate base of an alpha-D-ribose 1-methylphosphonate 5-triphosphate(4-).\n",
      "\n",
      "(S)-1'-methylbutyl caffeate is an alkyl caffeate ester obtained by the formal condensation of trans-caffeic acid with 2-pentanol\n",
      "Isolated from the leaves of Piper sanguineispicum, it has been shown to exhibit antileishmanial activity\n",
      "It has a role as a plant metabolite and an antileishmanial agent\n",
      "It derives from a pentan-2-ol.\n",
      "\n",
      "2-methylpentadecanal is a 2-methyl-branched fatty aldehyde that is pentadecanal in which a hydrogen at position 2 has been replaced by a methyl group\n",
      "It is a 2-methyl-branched fatty aldehyde and a saturated fatty aldehyde\n",
      "It derives from a pentadecanal.\n",
      "\n",
      "1-palmitoyl-2-oleoyl-3-stearoyl-sn-glycerol is a triacyl-sn-glycerol in which the acyl groups at positions 1, 2 and 3 are specifed as palmitoyl, oleoyl and stearoyl respectively\n",
      "It derives from an octadecanoic acid, an oleic acid and a hexadecanoic acid.\n",
      "\n",
      "3,22-dioxochol-4-en-24-oyl-CoA is a steroidal acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3,22-dioxochol-4-en-24-oic acid\n",
      "It is a conjugate acid of a 3,22-dioxochol-4-en-24-oyl-CoA(4-).\n",
      "\n",
      "(S)-quizalofop is a 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid that has S configuration\n",
      "It is the (inactive) enantiomer of the herbicide quizalofop-P\n",
      "It is an enantiomer of a quizalofop-P.\n",
      "\n",
      "Pinoxaden acid is an organic hydroxy compound resulting from the hydrolysis of the the pivalate ester group of the proherbicide pinoxaden\n",
      "It has a role as an agrochemical, an EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor, an environmental contaminant, a xenobiotic and a herbicide\n",
      "It is a pyrazolooxadiazepine, an organic hydroxy compound and a member of benzenes.\n",
      "\n",
      "(Kdo)2-lipid A (E. coli) is a member of lipid As, a dodecanoate ester and a tetradecanoate ester\n",
      "It has a role as an Escherichia coli metabolite\n",
      "It derives from a lipid A (E. coli)\n",
      "It is a conjugate acid of a (Kdo)2-lipid A(6-) (E. coli).\n",
      "\n",
      "Orbiculin I is a dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by an acetoxy group at position 1 and furoyloxy groups at positions 2, 6 and 9 (the 1beta,2beta,6alpha,9alpha stereoisomer)\n",
      "Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production\n",
      "It has a role as a metabolite and a NF-kappaB inhibitor\n",
      "It is an acetate ester, a bridged compound, a dihydroagarofuran sesquiterpenoid, a cyclic ether and an organic heterotricyclic compound\n",
      "It derives from a 3-furoic acid.\n",
      "\n",
      "3-O-Ac-alpha-D-GalpANAc-(1->4)-3-O-Ac-alpha-D-GalpANAc is an amino disaccharide that consists of two 2-acetamido-3-O-acetyl-2-deoxy-alpha-D-galactopyranuronosyl units joined by a (1->4)-linkage\n",
      "It is a carbohydrate acid derivative and an amino disaccharide.\n",
      "\n",
      "2,4-dioxopentanedioic acid is an oxodicarboxylic acid that is glutaric acid which is substituted by oxo groups at positions 2 and 4\n",
      "It is an oxo dicarboxylic acid and a beta-diketone.\n",
      "\n",
      "Alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-Glcp is a branched pentasaccharide consisting of a trisaccharide chain of alpha-D-galactose, beta-D-galactose and beta-D-glucose residues linked sequentially (1->3) and (1->4), with alpha-L-fucosyl residues attached by (1->2) and (1->3) linkages to the beta-D-galactose and beta-D-glucose residues respectively\n",
      "It derives from an alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp.\n",
      "\n",
      "Trans-3-hydroxy-L-proline zwitterion is zwitterionic form of trans-3-hydroxy-L-proline resulting from transfer of a proton from the carboxy to the amino group; major species at pH 7.3\n",
      "It is a tautomer of a trans-3-hydroxy-L-proline.\n",
      "\n",
      "Methyl 4-acetoxy-3-methoxycinnamate is a phenyl acetate obtained by the formal condensation of the carboxy group of acetic acid with the hydroxy group of methyl ferulate\n",
      "It is a cinnamate ester, a monomethoxybenzene and a member of phenyl acetates\n",
      "It derives from a ferulic acid.\n",
      "\n",
      "(S)-1-pyrroline-5-carboxylate is a 1-pyrroline-5-carboxylate resulting from the removal of the proton from the carboxy group of (S)-1-pyrroline-5-carboxylic acid\n",
      "It is a conjugate base of a (S)-1-pyrroline-5-carboxylic acid\n",
      "It is an enantiomer of a (R)-1-pyrroline-5-carboxylate.\n",
      "\n",
      "Tricosanoic acid is a very long-chain fatty acid that is tricosane in which one of the methyl groups has been oxidised to the corresponding carboxylic acid\n",
      "It has a role as a plant metabolite, a human metabolite and a Daphnia magna metabolite\n",
      "It is a straight-chain saturated fatty acid and a very long-chain fatty acid\n",
      "It is a conjugate acid of a tricosanoate.\n",
      "\n",
      "N-purin-6-oyl-epsilon-aminocaproic acid is a purine derivative that consists of 6-aminohexanoic acid having a purin-6-oyl group attached to the amino function via an amide bond\n",
      "It is a member of purines and a monocarboxylic acid amide\n",
      "It derives from a 6-aminohexanoic acid.\n",
      "\n",
      "Malvalic acid is a long-chain cyclopropenyl fatty acid comprising 8-heptadecenoic acid having a cyclopropene ring arising from the linking of C-8 and C-9 by a methylene substituent\n",
      "It is a cyclopropenyl fatty acid, a long-chain fatty acid and a monounsaturated fatty acid.\n",
      "\n",
      "1-deoxypentalenate is a monocarboxylic acid anion that is the conjugate base of 1-deoxypentalenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3\n",
      "It is a conjugate base of a 1-deoxypentalenic acid.\n",
      "\n",
      "Lipid X is an N-acyl-D-glucosamine 1-phosphate where the N-acyl group is (R)-3-hydroxytetradecanoyl and carrying an additional (R)-3-hydroxytetradecanoyl group at the 3-position\n",
      "It has a role as an Escherichia coli metabolite\n",
      "It is a conjugate acid of a lipid X(2-).\n",
      "\n",
      "(7alpha,22R)-dihydroxycholesterol is an oxysterol that is cholesterol which is substituted by hydroxy groups at positions 7alpha and 22R\n",
      "It is an oxysterol, a 7alpha-hydroxy steroid, a 22-hydroxy steroid, a cholestanoid and a 3beta-hydroxy-Delta(5)-steroid.\n",
      "\n",
      "Fluoroacetic acid is a haloacetic acid that is acetic acid in which one of the methyl hydrogens is substituted by fluorine\n",
      "It has a role as an EC 4.2.1.3 (aconitate hydratase) inhibitor\n",
      "It is an organofluorine compound and a haloacetic acid\n",
      "It is a conjugate acid of a fluoroacetate.\n",
      "\n",
      "15-oxolipoxin A4(1-) is a hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 15-oxolipoxin A4; major species at pH 7.3\n",
      "It is a hydroxy fatty acid anion, a polyunsaturated fatty acid anion, an oxo fatty acid anion, a long-chain fatty acid anion and an icosanoid anion\n",
      "It is a conjugate base of a 15-oxolipoxin A4.\n",
      "\n",
      "1-oleoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol is a 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 7Z,10Z,13Z,16Z-docosatetraenoyl respectively\n",
      "It has a role as a mouse metabolite\n",
      "It derives from an oleic acid and an all-cis-docosa-7,10,13,16-tetraenoic acid.\n",
      "\n",
      "9-hydroperoxy-10E-octadecenoic acid is a hydroperoxy fatty acid that is 9-hydroperoxy derivative of (10E)-octadecenoic acid\n",
      "It derives from an oleic acid\n",
      "It is a conjugate acid of a 9-hydroperoxy-10E-octadecenoate.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for spt in split_texts[500:550]:\n",
    "    # print(len(spt))\n",
    "    for s in spt:\n",
    "        print(s)\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "def balance_sentences(sentences):\n",
    "    total_words = sum(len(sentence.split()) for sentence in sentences)\n",
    "    midpoint = total_words // 2\n",
    "\n",
    "    accumulated_words = 0\n",
    "    first_part = []\n",
    "\n",
    "    for sentence in sentences:\n",
    "        accumulated_words += len(sentence.split())\n",
    "        first_part.append(sentence)\n",
    "        if accumulated_words >= midpoint:\n",
    "            break\n",
    "\n",
    "    second_part = sentences[len(first_part):]\n",
    "\n",
    "    return '. '.join(first_part), '. '.join(second_part)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paromomycin is an amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections\n",
      "It is also used as a therapeutic against visceral leishmaniasis. It has a role as an antibacterial drug, an antiprotozoal drug, an anthelminthic drug and an antiparasitic agent. It is an aminoglycoside antibiotic and an amino cyclitol glycoside. It derives from a streptamine.\n",
      "\n",
      "3-bromopyruvic acid is a 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is replaced by bromine. Synthetic brominated derivative and structural analog of pyruvic acid. Highly reactive alkylating agent. Anti-cancer drug It has a role as an alkylating agent and an antineoplastic agent\n",
      "It is a 2-oxo monocarboxylic acid and an organobromine compound. It derives from a pyruvic acid. It is a conjugate acid of a 3-bromopyruvate.\n",
      "\n",
      "D-serine is the R-enantiomer of serine. It has a role as a NMDA receptor agonist, a human metabolite and an Escherichia coli metabolite. It is a D-alpha-amino acid and a serine\n",
      "It is a conjugate base of a D-serinium. It is a conjugate acid of a D-serinate. It is an enantiomer of a L-serine. It is a tautomer of a D-serine zwitterion.\n",
      "\n",
      "L-histidine is the L-enantiomer of the amino acid histidine. It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is a proteinogenic amino acid, a histidine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-histidinium(1+). It is a conjugate acid of a L-histidinate(1-). It is an enantiomer of a D-histidine. It is a tautomer of a L-histidine zwitterion.\n",
      "\n",
      "Nocamycin I is an organic heterotricyclic compound and tetramic acid derivative originally isolated from an unidentified oligosporic actinomycete strain (no. E864-861) and found to be active against both Gram-positive and Gram-negative anaerobic bacteria as well as some aerobic bacteria such as Streptococci. The methyl ester of nocamycin E. It has a role as an antibacterial agent and a bacterial metabolite\n",
      "It is a spiroketal, a methyl ester, a gamma-lactam, an organic heterotricyclic compound, an olefinic compound, an enol and a member of tetramic acids. It derives from a nocamycin E. It is a conjugate acid of a nocamycin I(1-).\n",
      "\n",
      "4-phenylbutyric acid is a monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation\n",
      "It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an antineoplastic agent, an apoptosis inducer and a prodrug. It derives from a butyric acid. It is a conjugate acid of a 4-phenylbutyrate.\n",
      "\n",
      "L-mimosine is an L-alpha-amino acid that is propionic acid substituted by an amino group at position 2 and a 3-hydroxy-4-oxopyridin-1(4H)-yl group at position 3 (the 2S-stereoisomer). It a non-protein plant amino acid isolated from Mimosa pudica. It has a role as an EC 1.14.18.1 (tyrosinase) inhibitor and a plant metabolite\n",
      "It is a non-proteinogenic L-alpha-amino acid and a member of 4-pyridones. It derives from a propionic acid. It is a conjugate acid of a L-mimosine(1-). It is a tautomer of a L-mimosine zwitterion.\n",
      "\n",
      "Benserazide is a carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose\n",
      "Benserazide has no antiparkinson actions when given alone. It has a role as an EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor, an antiparkinson drug and a dopaminergic agent. It is a carbohydrazide, a member of catechols, a primary amino compound and a primary alcohol. It is a conjugate base of a benserazide(1+).\n",
      "\n",
      "Monapinone E is a naphthopyran that is 3,4-dihydronaphtho[2,3-c]pyran-1-one which is substituted by a (2R,4R)-2,4,9-trihydroxynonyl group at position 3 and a methoxy group at position 7. Published in Acta Pharm. Sin\n",
      "B, 2013, 3, 163-166. See also J. Antibiot., 2011, 64, 503-508. It is an aromatic ether, a member of phenols, a delta-lactone, a secondary alcohol, a primary alcohol and a naphtho-alpha-pyrone.\n",
      "\n",
      "L-methionine is the L-enantiomer of methionine. It has a role as a nutraceutical, a micronutrient, an antidote to paracetamol poisoning, a human metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, a methionine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-methioninium. It is a conjugate acid of a L-methioninate. It is an enantiomer of a D-methionine. It is a tautomer of a L-methionine zwitterion.\n",
      "\n",
      "Irinotecan is a member of the class of pyranoindolizinoquinolines that is the carbamate ester obtained by formal condensation of the carboxy group of [1,4'-bipiperidine]-1'-carboxylic acid with the phenolic hydroxy group of (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2- hydrochloride]quinoline-3,14-dione. Used (in the form of its hydrochloride salt trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active\n",
      "It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent and a prodrug. It is a pyranoindolizinoquinoline, a N-acylpiperidine, a carbamate ester, a tertiary alcohol, a tertiary amino compound, a delta-lactone and a ring assembly. It derives from a SN-38. It is a conjugate base of an irinotecan(1+).\n",
      "\n",
      "Methionine is a sulfur-containing amino acid that is butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4. It has a role as an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, a Daphnia magna metabolite and an algal metabolite\n",
      "It is an alpha-amino acid and a sulfur-containing amino acid. It derives from a butyric acid. It is a conjugate base of a methioninium. It is a conjugate acid of a methioninate. It is a tautomer of a methionine zwitterion.\n",
      "\n",
      "Lysine is a diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, a diamino acid and a polar amino acid\n",
      "It contains a 4-aminobutyl group. It derives from a hexanoic acid. It is a conjugate base of a lysinium(1+). It is a conjugate acid of a lysinate.\n",
      "\n",
      "N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide is a hydrobromide salt prepared from N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol and one equivalent of hydrogen bromide. High affinity, selective dopamine D1-like receptor agonist. Ki values are 3.2, 3.1, 186, 66, 335, 1167, 1251 and 1385 nM at recombinant D1, D5, D2, D3, D4, 5-HT2A, alpha1A and alpha1B receptors respectively\n",
      "Stimulates adenylyl cyclase (EC50 = 65 nM) but not phosphoinositide hydrolysis. Induces extreme arousal and hyperlocomotion following subcutaneous administration in monkeys. It has a role as a dopamine agonist and a prodrug. It contains a N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+).\n",
      "\n",
      "Ergothioneine is a L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group. A naturally occurring metabolite of histidine synthesized by bacteria and fungi with antioxidant properties. It is found ubiquitously in plants and animals and is present in many human foodstuffs\n",
      "It has a role as an antioxidant, a fungal metabolite, a plant metabolite, a xenobiotic metabolite and a chelator. It is an amino-acid betaine, a L-histidine derivative and a sulfur-containing amino acid. It is a conjugate base of an ergothioneine(1+). It is a tautomer of an ergothioneine thione form.\n",
      "\n",
      "TMC-52A is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-tyrosinamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52A acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 320 nM, 13 nM, and 44 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S)\n",
      "It has a role as an antimicrobial agent, a cathepsin L (EC 3.4.22.15) inhibitor, an EC 3.4.22.2 (papain) inhibitor, a cathepsin B inhibitor and a fungal metabolite. It is an epoxide, a monocarboxylic acid, a member of phenols, a primary amino compound, a secondary amino compound and a dicarboxylic acid monoamide.\n",
      "\n",
      "Oxycodone is a semisynthetic opioid of formula C18H21NO4 that is derived from thebaine. It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain. It has a role as an opioid analgesic, a mu-opioid receptor agonist and an antitussive\n",
      "It is an organic heteropentacyclic compound and a semisynthetic derivative. It derives from a thebaine. It is a conjugate base of an oxycodone(1+). It derives from a hydride of a morphinan.\n",
      "\n",
      "D-glutamine is the D-enantiomer of glutamine. It has a role as a mouse metabolite. It is a D-alpha-amino acid and a glutamine. It is a conjugate base of a D-glutaminium\n",
      "It is a conjugate acid of a D-glutaminate. It is an enantiomer of a L-glutamine. It is a tautomer of a D-glutamine zwitterion.\n",
      "\n",
      "TMC-52B is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{4-[(3-aminopropyl)amino]butyl}-L-tyrosinamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52B acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 200 nM, 10 nM, and 7 nM, respectively\n",
      "The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S). It has a role as a metabolite, an antimicrobial agent, a cathepsin B inhibitor, a cathepsin L (EC 3.4.22.15) inhibitor and an EC 3.4.22.2 (papain) inhibitor. It is an epoxide, a monocarboxylic acid, a member of phenols, a primary amino compound and a secondary amino compound.\n",
      "\n",
      "D-histidine is an optically active form of histidine having D-configuration. It has a role as a Saccharomyces cerevisiae metabolite. It is a D-alpha-amino acid and a histidine. It is a conjugate base of a D-histidinium(1+)\n",
      "It is a conjugate acid of a D-histidinate(1-). It is an enantiomer of a L-histidine. It is a tautomer of a D-histidine zwitterion.\n",
      "\n",
      "Bromfenac is amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure\n",
      "It has a role as a non-steroidal anti-inflammatory drug and a non-narcotic analgesic. It is a member of benzophenones, a substituted aniline, an aromatic amino acid and an organobromine compound. It derives from an amfenac. It is a conjugate acid of a bromfenac(1-).\n",
      "\n",
      "Dimenhydrinate is the diphenhydramine salt of 8-chlorotheophylline. Its effects are similar to those of diphenhydramine, but it is less potent. It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated\n",
      "However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline. Dimenhydrinate is used mainly as an antiemetic in the prevention and treatment of motion sickness. It has a role as a H1-receptor antagonist and an antiemetic. It contains a diphenhydramine and an 8-chlorotheophylline(1-).\n",
      "\n",
      "2-acetyl-1-pyrroline is a pyrroline that is 1-pyrroline in which the hydrogen at position 2 is replaced by an acetyl group. It is an aroma and flavour compound present in jasmine rice and basmati rice. It is responsible for the 'popcorn' aroma in a large variety of cereal and food products. It is one of the key odourants of the crust of bread and considered to be responsible for the cracker-like odour properties\n",
      "In bread, it is primarily generated during baking but amounts are influenced by ingredient composition and fermentation conditions. It has a role as a metabolite, a flavouring agent and a Maillard reaction product. It is a methyl ketone, a pyrroline and an acylimine.\n",
      "\n",
      "L-threonine is an optically active form of threonine having L-configuration. It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, a plant metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, a threonine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-threoninium. It is a conjugate acid of a L-threoninate. It is an enantiomer of a D-threonine. It is a tautomer of a L-threonine zwitterion.\n",
      "\n",
      "L-cysteine is an optically active form of cysteine having L-configuration. It has a role as a flour treatment agent, a human metabolite and an EC 4.3.1.3 (histidine ammonia-lyase) inhibitor. It is a serine family amino acid, a proteinogenic amino acid, a cysteine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-cysteinium. It is a conjugate acid of a L-cysteinate(1-). It is an enantiomer of a D-cysteine. It is a tautomer of a L-cysteine zwitterion.\n",
      "\n",
      "Cilastatin is the thioether resulting from the formal oxidative coupling of the thiol group of L-cysteine with the 7-position of (2Z)-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid. It is an inhibitor of dehydropeptidase I (membrane dipeptidase, 3.4.13.19), an enzyme found in the brush border of renal tubes and responsible for degrading the antibiotic imipenem. Cilastatin is therefore administered (as the sodium salt) with imipenem to prolong the antibacterial effect of the latter by preventing its renal metabolism to inactive and potentially nephrotoxic products\n",
      "Cilastatin also acts as a leukotriene D4 dipeptidase inhibitor, preventing the metabolism of leukotriene D4 to leukotriene E4. It has a role as a protease inhibitor, an EC 3.4.13.19 (membrane dipeptidase) inhibitor, a xenobiotic and an environmental contaminant. It is a non-proteinogenic L-alpha-amino acid, a L-cysteine derivative, an organic sulfide and a carboxamide. It is a conjugate acid of a cilastatin(1-).\n",
      "\n",
      "3-hydroxy-3-methylglutaric acid is a dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura\n",
      "It has a role as an antimetabolite, an anticholesteremic drug, an EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor, a human metabolite and a plant metabolite. It is a dicarboxylic acid, a 3-hydroxy carboxylic acid and a tertiary alcohol. It derives from a glutaric acid. It is a conjugate acid of a 3-hydroxy-3-methylglutarate(1-).\n",
      "\n",
      "Fosinopril is a phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite\n",
      "It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, a prodrug and an antihypertensive agent. It is a phosphinic ester and a L-proline derivative. It derives from a fosinoprilat. It is a conjugate acid of a fosinopril(1-).\n",
      "\n",
      "Aspirin-based probe AP is a benzoate ester resulting from the formal condensation of the carboxy group of acetylsalicylic acid with the phenolic hydroxy group of 2-(1,3-benzothiazol-2-yl)-4-fluorophenol. The latter is a fluorophore which is to the aspirin moiety via an H2O2-responsive bond. It can be used as probe for imaging H2O2 (overproduction of H2O2 causes oxidative stress and is characteristic of vascular diseases)\n",
      "In contrast to arylboronat-based probes, it shows high specificity for H2O2 over peroxynitrite (which is much more reactive than H2O2, but exists at much lower abundance). It has a role as a pharmaceutical. It is a benzoate ester, a member of benzothiazoles, a member of monofluorobenzenes and a member of salicylates. It derives from an acetylsalicylic acid and a 2-(1,3-benzothiazol-2-yl)-4-fluorophenol.\n",
      "\n",
      "L-serine is the L-enantiomer of serine. It has a role as a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a serine family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and a serine\n",
      "It is a conjugate base of a L-serinium. It is a conjugate acid of a L-serinate. It is an enantiomer of a D-serine. It is a tautomer of a L-serine zwitterion.\n",
      "\n",
      "Flufenpyr-ethyl is an ethyl ester resulting from the formal condesnation of the carboxy group of flufenpyr with ethanol. It is used as a contact herbicide for the control of broad-leaved weeds. It acts as a protoporphyrinogen oxidase inhibitor, causing protoporphyrins to accumulate, damaging the membrane structure and cellular function\n",
      "No longer approved for use in the European Union. It has a role as a herbicide, an agrochemical and an EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor. It is an ethyl ester, an aromatic ether, a pyridazinone, a member of monofluorobenzenes and a member of monochlorobenzenes. It derives from a flufenpyr.\n",
      "\n",
      "Vanoxerine dihydrochloride is a hydrochloride salt that is obtained by reaction of vanoxerine with two equivalents of hydrogen chloride. Potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers\n",
      "Also a potent sigma ligand (IC50 = 48 nM). Centrally active following systemic administration. It has a role as a dopamine uptake inhibitor. It contains a vanoxerine(2+).\n",
      "\n",
      "L-lysine is an L-alpha-amino acid; the L-isomer of lysine. It has a role as a micronutrient, a nutraceutical, an anticonvulsant, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, a lysine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-lysinium(1+). It is a conjugate acid of a L-lysinate. It is an enantiomer of a D-lysine. It is a tautomer of a L-lysine zwitterion.\n",
      "\n",
      "Stanozolol is an organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders\n",
      "It has also been widely abused by professional athletes. It has a role as an androgen and an anabolic agent. It is a 17beta-hydroxy steroid, a tertiary alcohol, an anabolic androgenic steroid and an organic heteropentacyclic compound. It derives from an oxymetholone.\n",
      "\n",
      "Fludarabine phosphate is a purine arabinonucleoside monophosphate having 2-fluoroadenine as the nucleobase. A prodrug, it is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. Once incorporated into DNA, 2-fluoro-ara-ATP functions as a DNA chain terminator. It is used for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to, or whose disease has progressed during, treatment with at least one standard alkylating-agent containing regimenas\n",
      "It has a role as an antimetabolite, an antineoplastic agent, an immunosuppressive agent, an antiviral agent, a prodrug and a DNA synthesis inhibitor. It is an organofluorine compound, a nucleoside analogue and a purine arabinonucleoside monophosphate. It derives from a 2-fluoroadenine.\n",
      "\n",
      "L-isoleucine is the L-enantiomer of isoleucine. It has a role as a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, an isoleucine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-isoleucinium. It is a conjugate acid of a L-isoleucinate. It is an enantiomer of a D-isoleucine. It is a tautomer of a L-isoleucine zwitterion.\n",
      "\n",
      "Imetit is an imidothiocarbamic ester that consists of isothiourea in which the thiol hydrogen is substituted by a 2-(imidazol-4-yl)ethyl group. An extremely potent, high affinity agonist at H3 and H4 receptors (Ki values are 0.3 and 2.7 nM respectively). Induces shape change in eosinophils with an EC50 of 25 nM\n",
      "Centrally active following systemic administration. It has a role as a H3-receptor agonist and a H4-receptor agonist. It is a member of imidazoles and an imidothiocarbamic ester. It is a conjugate base of an imetit(2+).\n",
      "\n",
      "Tyrosine is an alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, a polar amino acid and an aromatic amino acid\n",
      "It contains a 4-hydroxybenzyl group. It derives from a propionic acid. It is a conjugate base of a tyrosinium. It is a conjugate acid of a tyrosinate(1-).\n",
      "\n",
      "3-hydroxyanthranilic acid is an aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan. It has a role as a human metabolite and a mouse metabolite\n",
      "It is an aminobenzoic acid and a monohydroxybenzoic acid. It derives from an anthranilic acid. It is a conjugate acid of a 3-hydroxyanthranilate. It is a tautomer of a 2,3-dihydro-3-oxoanthranilic acid.\n",
      "\n",
      "Midodrine is an aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine\n",
      "It has a role as a prodrug, an alpha-adrenergic agonist, a sympathomimetic agent and a vasoconstrictor agent. It is a secondary alcohol, an amino acid amide and an aromatic ether. It derives from a glycinamide and a deglymidodrine. It is a conjugate base of a midodrine(1+).\n",
      "\n",
      "D-tyrosine is an optically active form of tyrosine having D-configuration. It has a role as an Escherichia coli metabolite. It is a tyrosine and a D-alpha-amino acid. It is a conjugate base of a D-tyrosinium\n",
      "It is a conjugate acid of a D-tyrosinate(1-). It is an enantiomer of a L-tyrosine. It is a tautomer of a D-tyrosine zwitterion.\n",
      "\n",
      "D-alanine is the D-enantiomer of alanine. It has a role as a human metabolite, an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and an Escherichia coli metabolite. It is a D-alpha-amino acid and an alanine\n",
      "It is a conjugate base of a D-alaninium. It is a conjugate acid of a D-alaninate. It is an enantiomer of a L-alanine. It is a tautomer of a D-alanine zwitterion.\n",
      "\n",
      "Tryptophan is an alpha-amino acid that is alanine bearing an indol-3-yl substituent at position 3. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, an aminoalkylindole, a polar amino acid and an aromatic amino acid\n",
      "It contains a 1H-indol-3-ylmethyl group. It is a conjugate base of a tryptophanium. It is a conjugate acid of a tryptophanate. It is a tautomer of a tryptophan zwitterion.\n",
      "\n",
      "L-asparagine is an optically active form of asparagine having L-configuration. It has a role as a nutraceutical, a micronutrient, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a mouse metabolite and a plant metabolite. It is an aspartate family amino acid, a proteinogenic amino acid, an asparagine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-asparaginium. It is a conjugate acid of a L-asparaginate. It is an enantiomer of a D-asparagine. It is a tautomer of a L-asparagine zwitterion.\n",
      "\n",
      "Mycophenolic acid is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases\n",
      "It has a role as an antineoplastic agent, an antimicrobial agent, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor, an immunosuppressive agent, a mycotoxin, a Penicillium metabolite, an environmental contaminant, a xenobiotic and an anticoronaviral agent. It is a gamma-lactone, a member of phenols, a monocarboxylic acid and a member of 2-benzofurans. It derives from a hex-4-enoic acid. It is a conjugate acid of a mycophenolate.\n",
      "\n",
      "TMC-52C is an epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-phenylalaninamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52C acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 460 nM, 10 nM, and 88 nM, respectively\n",
      "The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S). It has a role as an antimicrobial agent, a cathepsin B inhibitor, a cathepsin L (EC 3.4.22.15) inhibitor, an EC 3.4.22.2 (papain) inhibitor and a fungal metabolite. It is an epoxide, a monocarboxylic acid, a primary amino compound, a secondary amino compound and a dicarboxylic acid monoamide.\n",
      "\n",
      "(R)-lipoic acid is the (R)-enantiomer of lipoic acid. A vitamin-like, C8 thia fatty acid with anti-oxidant properties. It has a role as a prosthetic group, a nutraceutical and a cofactor. It is a lipoic acid, a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid\n",
      "It derives from an octanoic acid. It is a conjugate acid of a (R)-lipoate. It is an enantiomer of a (S)-lipoic acid.\n",
      "\n",
      "Methiothepin is a dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively)\n",
      "It has a role as an antipsychotic agent, a dopaminergic antagonist and a serotonergic antagonist. It is a N-alkylpiperazine, a dibenzothiepine, an aryl sulfide and a tertiary amino compound. It is a conjugate base of a methiothepin(2+).\n",
      "\n",
      "WIN 18446 is a carboxamide that is 1,8-diaminooctane in which a hydrogen attached to each of the amino groups has been replaced by a dichloroacetyl group. Inhibitor of aldehyde dehydrogenase 1a2 (ALDH1a2). Inhibits the biosynthesis of retinoic acid from retinol in neonatal and adult murine testis\n",
      "It down-regulates sex related genes in zebrafish. It has a role as an EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor. It is an organochlorine compound and a secondary carboxamide. It derives from a dichloroacetic acid and a 1,8-diaminooctane.\n",
      "\n",
      "L-phenylalanine is the L-enantiomer of phenylalanine. It has a role as a nutraceutical, a micronutrient, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, an algal metabolite, a mouse metabolite, a human xenobiotic metabolite and an EC 3.1.3.1 (alkaline phosphatase) inhibitor. It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a phenylalanine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-phenylalaninium. It is a conjugate acid of a L-phenylalaninate. It is an enantiomer of a D-phenylalanine. It is a tautomer of a L-phenylalanine zwitterion.\n",
      "\n",
      "L-alanine is the L-enantiomer of alanine. It has a role as an EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor and a fundamental metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and an alanine\n",
      "It is a conjugate base of a L-alaninium. It is a conjugate acid of a L-alaninate. It is an enantiomer of a D-alanine. It is a tautomer of a L-alanine zwitterion.\n",
      "\n",
      "Carmoxirole is an indolecarboxylic acid that is indole-5-carboxylic acid bearing an additional 4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl substituent at position 3. Selective, peripherally acting dopamine D2 receptor agonist. Modulates noradrenalin release and sympathetic activation. Displays antihypertensive properties in vivo\n",
      "It has a role as an antihypertensive agent, a dopamine agonist and a platelet aggregation inhibitor. It is an indolecarboxylic acid, a tetrahydropyridine and a tertiary amino compound. It is a conjugate base of a carmoxirole(1+).\n",
      "\n",
      "Thiocyclam is an organosulfur heterocyclic compound that is 1,2,3-trithiane in which one of the hydrogens at position 5 has been replaced by a dimethylamino group. A nicotinic acetylcholine receptor agonist, it was used (particularly as its hydrogen oxalate salt, known as thyocyclam oxalate) as a broad-spectrum insecticide, but it is also toxic to bees, fish and other aquatic organisms\n",
      "It is not approved for use within the European Union. It has a role as an agrochemical and a nicotinic acetylcholine receptor agonist. It is a nereistoxin analogue insecticide and an organosulfur heterocyclic compound. It is a conjugate base of a thiocyclam(1+). It derives from a hydride of a 1,2,3-trithiane.\n",
      "\n",
      "Serine is an alpha-amino acid that is alanine substituted at position 3 by a hydroxy group. It has a role as a fundamental metabolite. It is an alpha-amino acid and a polar amino acid\n",
      "It contains a hydroxymethyl group. It is a conjugate base of a serinium. It is a conjugate acid of a serinate. It is a tautomer of a serine zwitterion.\n",
      "\n",
      "(-)-echitovenine(1+) is an ammonium ion resulting from the protonation of the tertiary amino group of (-)-echitovenine. The major species at pH 7.3. Note the stereoconfiguration of the 19 hydroxy group is based on CHEBI:144373 (and Fig\n",
      "S10). It is an ammonium ion derivative and an indole alkaloid cation. It is a conjugate acid of a (-)-echitovenine. It is an enantiomer of a (+)-echitovenine(1+).\n",
      "\n",
      "D-proline is the D-enantiomer of proline. It has a role as a mouse metabolite. It is a D-alpha-amino acid and a proline. It is a conjugate base of a D-prolinium\n",
      "It is a conjugate acid of a D-prolinate. It is an enantiomer of a L-proline. It is a tautomer of a D-proline zwitterion.\n",
      "\n",
      "L-leucine is the L-enantiomer of leucine. It has a role as a plant metabolite, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a leucine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-leucinium. It is a conjugate acid of a L-leucinate. It is an enantiomer of a D-leucine. It is a tautomer of a L-leucine zwitterion.\n",
      "\n",
      "4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide is a benzamide obtained by formal condensation of the carboxy group of 4-fluorobenzoic acid with the primary amino group of 2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethylamine. Highly potent selective 5-HT1A receptor full agonist (pKi values are 9.0, 6.6, 7.5, 6.6 and < 6.0 for 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 receptors respectively). Possibly binds between the agonist binding site and the G protein interaction switch site, affecting the activation mechanism, and may display positive cooperativity\n",
      "Anxiolytic following central administration in vivo. It has a role as an anxiolytic drug and a serotonergic agonist. It is a N-arylpiperazine, a N-alkylpiperazine, a methoxynaphthalene, a member of benzamides and an organofluorine compound. It is a conjugate base of a 4-fluoro-N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}benzamide(1+).\n",
      "\n",
      "L-valine is the L-enantiomer of valine. It has a role as a nutraceutical, a micronutrient, a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a pyruvate family amino acid, a proteinogenic amino acid, a valine and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-valinium. It is a conjugate acid of a L-valinate. It is an enantiomer of a D-valine. It is a tautomer of a L-valine zwitterion.\n",
      "\n",
      "Sumatriptan is a sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults\n",
      "It has a role as a serotonergic agonist and a vasoconstrictor agent. It is a sulfonamide and a member of tryptamines. It derives from a N,N-dimethyltryptamine. It is a conjugate acid of a sumatriptan(1+).\n",
      "\n",
      "(R)-3-hydroxybutyric acid is the R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis\n",
      "It has a role as a human metabolite, a pheromone and a fungal metabolite. It is a ketone body and a 3-hydroxybutyric acid. It is a conjugate acid of a (R)-3-hydroxybutyrate. It is an enantiomer of a (S)-3-hydroxybutyric acid.\n",
      "\n",
      "L-tryptophan is the L-enantiomer of tryptophan. It has a role as an antidepressant, a nutraceutical, a micronutrient, a plant metabolite, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an erythrose 4-phosphate/phosphoenolpyruvate family amino acid, a proteinogenic amino acid, a tryptophan and a L-alpha-amino acid\n",
      "It is a conjugate base of a L-tryptophanium. It is a conjugate acid of a L-tryptophanate. It is an enantiomer of a D-tryptophan. It is a tautomer of a L-tryptophan zwitterion.\n",
      "\n",
      "Diclocymet is a diastereoisomeric mixture comprising equimolar amounts of (1R,2S)- and (1R,2R)-diclocymet. A fungicide used for the control of rice blast in paddy fields. It also shows some activity against paddy field insect pests including rice water weevil and rice-stem borer\n",
      "Diclocymet is moderately toxic to fish. It has a role as a xenobiotic, an insecticide, a melanin synthesis inhibitor and an antifungal agrochemical. It is a diastereoisomeric mixture and an amide fungicide. It contains a (1R,2S)-diclocymet and a (1R,2R)-diclocymet.\n",
      "\n",
      "Morphine is a morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). It has a role as an opioid analgesic, a mu-opioid receptor agonist, a plant metabolite, an environmental contaminant, a xenobiotic, a vasodilator agent, an anaesthetic and a drug allergen\n",
      "It is an organic heteropentacyclic compound, a tertiary amino compound and a morphinane alkaloid. It is a conjugate base of a morphine(1+). It derives from a hydride of a morphinan.\n",
      "\n",
      "Se-methyl-L-selenocysteine is an L-alpha-amino acid compound having methylselanylmethyl as the side-chain. It has a role as an antineoplastic agent. It is a Se-methylselenocysteine, a non-proteinogenic L-alpha-amino acid and a L-selenocysteine derivative\n",
      "It is a conjugate base of a Se-methyl-L-selenocysteinium. It is a conjugate acid of a Se-methyl-L-selenocysteinate. It is an enantiomer of a Se-methyl-D-selenocysteine. It is a tautomer of a Se-methyl-L-selenocysteine zwitterion.\n",
      "\n",
      "4-hydroxyphenyl retinamide is a retinoid obtained by formal condensation of the carboxy group of all-trans retinoic acid and the anilino group of 4-hydroxyaniline. Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo. Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids\n",
      "It has a role as an antineoplastic agent and an antioxidant. It is a retinoid and a monocarboxylic acid amide. It derives from an all-trans-retinoic acid.\n",
      "\n",
      "CGP 78608 is a phosphonic acid in which the hydrogen attached to phosphorous is substituted by a 1-{[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]amino}ethyl group. Potent and selective NMDA antagonist that acts through the glycine site (IC50 = 5 nM). Displays >500-fold selectivity over kainate and AMPA receptors (IC50 values are 2.7 and 3 muM respectively)\n",
      "Anticonvulsant in vivo following systemic administration. It has a role as a NMDA receptor antagonist and an anticonvulsant. It is a quinoxaline derivative, an organobromine compound, a secondary amino compound and a member of phosphonic acids. It contains a CGP 78608(1+).\n",
      "\n",
      "6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator. It has a role as an antifibrinolytic drug, a hematologic agent and a metabolite\n",
      "It is an epsilon-amino acid and an omega-amino fatty acid. It derives from a hexanoic acid. It is a conjugate acid of a 6-aminohexanoate. It is a tautomer of a 6-aminohexanoic acid zwitterion.\n",
      "\n",
      "Ascr#10 is an (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (8R)-8-hydroxynonanoic acid with ascarylopyranose (the alpha anomer). A metabolite of the nematode Caenorhabditis elegans, it is the direct biosynthetic precursor to ascr#3. It has also been detected in the sour paste nematode, Panagrellus redivivus\n",
      "It has a role as a Caenorhabditis elegans metabolite. It is a monocarboxylic acid and an (omega-1)-hydroxy fatty acid ascaroside. It derives from an (8R)-8-hydroxynonanoic acid. It is a conjugate acid of an ascr#10(1-).\n",
      "\n",
      "Methoxsalen is a member of the class of psoralens that is 7H-furo[3,2-g]chromen-7-one in which the 9 position is substituted by a methoxy group. It is a constituent of the fruits of Ammi majus. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered topically or orally in conjunction with UV-A for phototherapy treatment of vitiligo and severe psoriasis\n",
      "It has a role as a dermatologic drug, an antineoplastic agent, a photosensitizing agent, a cross-linking reagent and a plant metabolite. It is a member of psoralens and an aromatic ether. It derives from a psoralen.\n",
      "\n",
      "Sarcosine is a N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine. It has a role as a glycine transporter 1 inhibitor, a glycine receptor agonist, a human metabolite, an Escherichia coli metabolite and a mouse metabolite\n",
      "It is a N-alkylglycine, a N-methyl-amino acid and a member of N-methylglycines. It is a conjugate base of a sarcosinium. It is a conjugate acid of a sarcosinate. It is a tautomer of a sarcosine zwitterion.\n",
      "\n",
      "L-selenocysteine is the L-enantiomer of selenocysteine. It has a role as a human metabolite. It is a L-alpha-amino acid, a selenocysteine, a proteinogenic amino acid and a L-alanine derivative. It is a conjugate base of a L-selenocysteinium\n",
      "It is a conjugate acid of a L-selenocysteinate(1-). It is an enantiomer of a D-selenocysteine. It is a tautomer of a L-selenocysteine zwitterion.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i in range(len(split_texts)):\n",
    "    if len(split_texts[i]) == 7:\n",
    "        bl = balance_sentences(split_texts[i])\n",
    "        for s in bl:\n",
    "            print(s)\n",
    "        print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
